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4Re´sume´
Comme de´montre´ re´cemment pour la re´ge´ne´ration du foie apre`s un dommage cause´ par
intoxication, l’organisation et les processus de croissance peuvent eˆtre syste´matiquement
analyse´s par un protocole d’expe´riences, d’analyse d’images et de mode´lisation [43]. Les
auteurs de [43] ont quantitativement caracte´rise´ l’architecture des lobules du foie, l’unite´
fonctionnelle fondamentale qui constitue le foie, et en ont conc¸u un mode`le mathe´matique
capable de pre´voir un me´canisme jusqu’alors inconnu de division ordonne´e des cellules.
La pre´diction du mode`le fut ensuite valide´e expe´rimentalement. Dans ce travail, nous
e´tendons ce mode`le a` l’e´chelle de plusieurs lobules sur la base de re´sultats expe´rimentaux
sur la carcinoge´ne`se dans le foie [15]. Nous explorons les sce´narios possibles pouvant
expliquer les diffe´rents phenotypes de tumeurs observe´s dans la souris. Notre mode`le
repre´sente les he´patocytes, principal type de cellule dans le foie, comme des unite´s indi-
viduels avec un mode`le a` base d’agents centre´ sur les cellules et le syste`me vasculaire est
represente´ comme un re´seau d’objets extensibles. L’e´quation de Langevin qui mode´lise
le mouvement des objets est calcule´e par une discre´tisation explicite. Les inte´ractions
me´caniques entre cellules sont mode´lise´es avec la force de Hertz ou de JKR. Le mode`le
est parame´tre´ avec des valeurs mesurables a` l’e´chelle de la cellule ou du tissue et ses
re´sultats sont directement compare´s avec les re´sultats expe´rimentaux.
Dans une premie`re e´tape fondamentale, nous e´tudions si les voies de transduction du
signal de Wnt et Ras peuvent expliquer les observations de [15] ou` une proliferation in-
stantanne´e dans les souris mute´es est observe´e seulement si 70% des he´patocytes sont
de´pourvues d’APC. Dans une deuxie`me e´tape, nous pre´sentons une analyse de sensi-
bilite´ du mode`le sur la rigidite´ de la vasculature et nous la mettons en relation avec un
phenotype de tumeur (observe´ expe´rimentalement) ou` les cellules tumorales sont bien
diffe´rentie´es. Nous inte´grons ensuite dans une troisie`me e´tape la destruction de la vascu-
lature par les cellules tumorales et nous la mettons en relation avec un autre phe´notype
observe´ expe´rimentalement caracte´rise´ par l’absence de vaisseaux sanguins. Enfin, dans
la dernie`re e´tape de notre e´tude nous montrons que des effets qui sont de´tectables dans les
petits nodules tumoraux et qui refle`tent les proprie´te´s des cellules tumorales, ne sont plus
pre´sents dans la forme ou dans le phenotype des tumeurs d’une taille exce´dant la moitie´
de celle d’un lobule.
5Abstract
As recently demonstrated for liver regeneration after drug-induced damage, organization
and growth processes can be systematically analyzed by a process chain of experiments,
image analysis and modeling [43]. The authors of [43] were able to quantitatively char-
acterize the architecture of liver lobules, the repetitive functional building blocks of liver,
and turn this into a quantitative mathematical model capable to predict a previously unrec-
ognized order mechanism. The model prediction could subsequently be experimentally
validated. Here, we extend this model to the multi-lobular scale, guided by experimen-
tal findings on carcinogenesis in liver [15]. We explore the possible scenarios leading to
the different tumor phenotypes experimentally observed in mouse. Our model considers
the hepatocytes, the main cell type in liver, as individual units with a single cell based
model and the blood vessel system as a network of extensible objects. Model motion is
computed based on explicit discretized Langevin equation and cell interactions are either
Hertz or JKR forces. The model is parameterized by measurable values on the cell and
tissue scale and its results are directly compared to the experimental findings.
In a fundamental first step we study if Wnt and Ras signaling pathways can explain
the observation of [15], that instantaneous proliferation in mutated mice can only be ob-
served if around 70% of the hepatocytes become APC depleted. In a second step, we
show a sensitivity analysis of the model on the vessel stiffness and relate it to a tumor
phenotype (experimentally observed) where the tumor cells are well differentiated. We
integrate in a third step the destruction of vasculature by tumor cells to relate it to another
experimentally observed tumor phenotype characterized by the absence of blood vessels.
Finally, in the last step we show that effects that are detectible for small tumor nodules
and reflect properties of the tumor cells, are not reflected in the tumor shape or phenotype
at tumor sizes exceeding half of the lobule size.
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Introduction
“Biological experiments are expensive and depend on many parameters that are mostly
difficult to control and test in isolation. As a complementary method, mathematical
modeling and in silico experiments are a good candidate to help explore the behavior
of the individual tissue cells along with investigating their response to environmental
cues” [47]
What is Systems Biology ?
Systems biology is a new branch of science that wants to embed a not so new idea: ”the
whole is more than the sum of its parts”. Aristotle in his Metaphysics has already de-
veloped this idea. Life is a good example to illustrate this concept. Intuitively, living
organisms seem to be more than a sum of atoms. Some properties of life are not con-
tained in atoms but emerge from complex interactions. This is what systems biology aims
at understanding: emergent properties. To study such complex systems with all possible
interactions, systems biology requires gathering knowledge and skills from many disci-
plines. A new paradigm has been suggested to face this task: Holism. Holism purpose
is to include in the study the different interactions, for different scales, from different
scientific fields. This new methodology is opposed to the traditional reductionist method
theorized by Rene´ Descartes [53, 77]. Reductionism consists in splitting problems in
small parts supposed being solvable independently. Reductionism opponents think that
unlikely this method is unable to catch global properties coming from the union of small
sub-problems and thus miss the emergent properties. In other words, reductionism is criti-
cized because it takes apart and over simplifies. This simplification is believed to fail with
complex systems.
Computers are stupid
Holism suggests thinking differently in order to embrace the problems but does not give so
far a clear description to do it. Denis Noble, one of the pioneers in systems biology gave a
list of holistic principles for systems biology [67]. These principles need to be interpreted
in order to be applied in daily scientific work especially if one works with computers. To-
day, no programming language exists for the holistic point of view. Computers are stupid
and they need to reduce problems even more than it is needed for the human brain [10].
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Computer programs represent reductionism approach at its climax: numbers are trun-
cated, memory, time and space are finite and discretized, and operations must be ordered
– two actions are never performed at the same time, not like in reality. One immediate
benefit from this imposed and drastic reduction is that programs are logically speaking
consistent. From the results of simulations, causes and consequences may be logically
connected and classified more easily because the translation of a model into a program is
rigorous – computers cannot deal with ambiguities. Moreover computers don’t prevent
models to exhibit emergent properties even with very simple programs [12]. Finally, we
may add an authority argument and recall that holism has been developed recently and
does not benefit from success of its reductionist concurrent that helped science to build
its actual knowledge since centuries. For those reasons, we decided to work traditionally
even if the field is emergent. Hoping that we would not bore the reader hungry of brilliant
novelties, we think we chose the safer path for scientific work.
What we know about reality
The following discussion about perception of reality is not proper to our scientific domain
but we think it is important to emphasize how blind systems biology is to the reality
problems it deals with. The main reason of the distance between reality and perception
comes from the nature of observables. A single cell may have dozens of thousands of
proteins interacting with each other.
Speaking about huge numbers, John D. Barrow in [5] suggests talking not about as-
tronomic numbers anymore but biological numbers. For instance, he shows by a little
computation that a neuron may have possibly interactions with 10180 other neurons re-
membering that the number of atoms in the universe is 1080. This vertiginous figure
explains the huge variability that exists in experimental biology. Since the end of the
20th century, scientists are equipped with a new weapon: computers and their increasing
computation power. Even if computational power will always remain insufficient to reach
the numbers quoted by Barrow, computers proved their ability to help in classifying huge
amount of data. In order to get a chance of understanding so complex systems, a large
quantity of results should be produced. The variability of the experimental data should
be smoothed by the large amount and their systematical analysis. Particular cases and
new concepts should emerge from the contradictory data. In other words, quantity is sup-
posed to counter complexity of life. Systematic analysis has become possible thanks to
computers and systems biology as an inter-disciplinary field takes advantage of this tool.
Probably, it is the way around and we could ask if computing power itself did not create
systems biology? At least, computers have made systems biology feasible.
How to deal with complex systems?
By simulating situations with different assumptions, it is possible to test hypotheses, to
discard some and keep the more plausible ones. Simulations can help directly to under-
stand complex systems but also indirectly by guiding experimentalist in the multitude
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(a) Reality can be complicated and complex.
Most of the time, we could get only truncated
screenshots of it from different situations.
(b) Experiments can give only a certain resolution
of this reality which starts already to mislead the
analysis
(c) Mathematical modeling or idealization even
fully detailed cannot be more than an approxima-
tion of the observations.
(d) Simulation deforms the model by the numeri-
cal assumptions needed for the computation.
Figure 1: Schematic illustration of the reality seen through the eye of a modeler. If inputs
of the model were images of entwined fisher nets, we schematize what would be the model
idealization of it. (Image from photo-libre.fr freely distorted)
of paths they may choose. Simulations should be seen as catalyzers for understanding
faster real cases. Simulations reduce the number of possibilities without need for addi-
tional experiments. Thanks to this virtual tool, Science saves of course time and money
but also the lives of animals1. The field is new but already yielded a substantial amount
of success. We did not start from scratch but walked in the steps of our predecessors.
The model presented in this work have been largely inspired by others, all applied to bi-
ological problems [29, 27, 68, 73, 82, 2]. In particular, the first stone of the modeling
of angiogenesis can be find in [4] that largely inspired our way to consider the vascular
network. Interested reader about angiogenesis can refer to [63, 61], also important papers
in the mathematical modeling of angiogenesis. We especially refer to previous work of
our team and published in [43]. For those reasons, we selected the simulation approach
to deal with complex systems. This work invested a lot of effort to build a tool capable to
1all important issues to get European founds
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properly simulate different models.
The final simulation result of one model is not enough to provide any reasonable argu-
ment to make conclusions about reality (see fig. 1). The only way is to proceed through
numbers and repetitions. Iterations over experiments and simulations eliminate artifacts,
dissociate particular and general, and distinguish errors and fluctuations of the measure-
ments. Only after several iterations can the modeler emphasize relevant mechanisms and
suggest new experiments to demonstrate his purpose. The loop process can be summa-
rized by the following scheme (see fig. 2).
Figure 2: Process loop: A pilot experiment starts the chain. This experiment leads, at
the end of the cycle, to new experiments to confirm the explanation. Most of the time,
predictions are open. Several possibilities still exist. After some iterations of this process
chain, the number should decrease to lead to reliable explanations of the experiment.
We described in details the methodology of our work and some parts can be trivial. As
a new and inter-disciplinary branch of science, the methodology is still under development
and we decided to emphasize on this part of our work because organization in systems
biology is needed not only to be efficient but also simply to be able to accomplish our
task.
Organization of the thesis
The work presented here is at the crossroads of many scientific domains. To help the
reader, we supplemented this document with a glossary and an appendix.
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The first chapter presents a brief review of Agent-Based Models (ABMs) to make the
reader familiar with this model concept (a complete and recent review can be found in
[50]). We present the assumptions that led to the physical and mathematical framework of
the model. We introduce the model by explaining the choices (motivations and references)
that led to adapt the model that way from the validated model published in [44, 41]. We
describe the cell shape, motion, growth and death control, interactions with other cells,
active movement, angular momentum and molecular transport.
In the second chapter, we describe algorithms and necessary components to simulate
the agent-based model presented in the first chapter. Due to the complexity of the prob-
lem, many challenges had to be faced and the implementation occupied a large part of
the working time. Technical description is developed in order to be reproducible: pro-
gram language, libraries, algorithms, numerical schemes, parallelization and solvers. We
show benchmarks that compare program efficiency of the sequential version to the par-
allel version. The choice of the programming language was guided by our needs, which
are:
• Modularity: the model should be open to extensions without a full re-organization
of the code.
• Collaborative: the code should be readable and understandable rapidly by collabo-
rators.
• Fast: the simulations deal with a large number of elements. The program must be
fast enough (optimized compilers, optimized algorithms).
• Robustness: A debugging method should be applicable on the code to ensure a
minimum of implementation error.
The aims of the simulator are to compute the equations of the model with an initial in-
put and to output and analyze the results. Many functions that simulate or analyze the
model are too trivial and can be straight-forward programmed even though the time to
include them in a code can be long. We present selected algorithms and numerical meth-
ods we used to compute the Langevin equation: numeral issues, numerical schemes, main
algorithm, parallel sparse matrix solver and parallel contact detection.
In the third chapter, we present the main application of the model: the liver cancer.
Despite the large efforts over the last decades, cancer is a leading cause of death. The
complexity of the disease has now led to requests of support to the mathematical com-
munity [28]. Colnot et al. [15] have developed an interesting liver in vivo cancer mouse
model. The model could explain some aspects of the human liver cancer but also pointed
a number of questions. What could explain that hepatocyte proliferation is triggered only
if 70% of the cells are APC depleted? What could explain that APC depletion leads to
two distinct tumor phenotypes? How could distinguish different phenotype in early devel-
opment? We adapted the model introduced above to address these questions by studying
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the possible influence of different mechanisms on carcinogenesis by simulations with an
in silico liver model. We detail the biological information necessary for this application,
namely: the liver cancer, the mouse model, its data and questions, and the model speci-
ficities that we had to include to mimic possible scenarios of carcinogenesis in liver. This
chapter also described additional model specifications and assumptions. We used the data
extracted in [42] to build a representative sample of lobules. We describe the novelties
introduced and split the results in five sections: In the first section, we present the re-
sults of an integrated model of the Wnt and β -catenin signal transduction pathways into
the multi-cellular model. We perform the integration into a monolayer and choose the
boundary condition in analogy to those in a liver lobule. In a fundamental first step we
study if Wnt and Ras signaling pathways can explain the observation of [15], that in-
stantaneous proliferation in Apclox/lox mice can only be observed if around 70% of the
hepatocytes become Apc-/-. The liver functions are dependent on the liver tissue organi-
zation. In this tissue, the vasculature plays a crucial role. In the second result section, we
show a sensitivity analysis of the model on the vessel stiffness and relate it to the well-
differentiated phenotype. In the mouse model, biologists observed poorly differentiated
tumor after APC cell depletion. This tumor phenotype is characterized by the absence
of blood vessels. We integrated this information by including destruction of vasculature
by tumor cells and performed a sensitivity analysis that is shown in the third section. In
above sections 2 and 3, we studied the emergence of different tumor phenotypes. We did
not, however, study any mechanism affecting tumor symmetry, and how the tumor phe-
notype is expected to vary with tumor size beyond a nodule size. In the rat experimental
model where tumors can be initiated in a controlled way, small tumors can be observed
while in human patients at the time point of clinical manifestation, tumors are usually of
centimeter size. The tumor shape at tumor initiation may reflect important information
on the underlying mechanism. Hence it is important to know if effects that are detectible
for small tumor nodules and reflect properties of the tumor cells, may still be reflected
in the tumor shape or phenotype at tumor sizes exceeding the distance between the cen-
tral and periportal vein. We show in the fourth section simulations focusing on those
aspects. Finally in the last result section, we present simulations after various stimulation
patterns. The possible number of combinations of assumptions is too large to be tested
in its entirety. However, we performed many simulations to explore the most realistic
configurations. We presented in previous sections the most concluding ones. To obtain
them, many simulations had to be performed. The results presented in this section is a
selection of results that guided the thinking and allowed us to present a straight forward
reasoning and also to justify some affirmations in the argumentation line. Despite their
modest influence on tumor growth, the stimulation patterns presented below permitted to
understand the relevant mechanisms and discard the ones with small impact. Moreover,
they obliged us to find new measurements and new strategies to reach the goals of the pre-
vious sections. We present the results here to show that our exploration was not restrained
to only few mechanisms but covered a large span of possibilities.
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The last chapter summarizes the results and present perspectives and other current ap-
plications of the model.
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Chapter 1
Model description
La diffe´rence entre les the´ories des
biologistes et celles des
mathe´maticiens sur la biologie est
la meˆme qu’entre les the´ories
d’e´ducation des enfants pour les
personnes qui ont des enfants et
ceux qui n’en ont pas.
IN TU¨BINGEN, Sabine Colnot
1.1 Model framework
In brief:
This section presents briefly agent-based models to make the reader familiar with this
model concept. A complete and recent review can be found in [50]. We introduce here
the model (with equations) by explaining the choices (motivations and references) that
leaded to adapt the model that way from validated model published in [44, 41].
1.1.1 Agent-based models
The biological problem we are interested in and that we present in a further chapter, takes
place at the cell scale. In particular, its purpose is to understand the differences between
several cell types where the differences are physical cell properties. Agent-based mod-
els (ABM) offer numerous advantages over continuum models for this type of problem.
ABM are also called individual-based models. We prefer naming our objects agents be-
cause they are not individual neither indivisible (as etymology of ”individual” suggests).
Continuum models use locally averaged quantities (like cell density for instance) where
19
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the discrete nature of the problems scaled at cell size becomes critical. Formally, it should
be possible to translate most of ABM in continuum models for scales that are greater than
cell scale. Even though, the translation remains a complicated issue [57].
ABM modeling nature – so called bottom-up approach – is such that each assumption
on physics, biology or social can be explicitly incorporated. Let there be the light, and
the light is. Naming the process, is modeling the process. ABM approach is intuitive and
pertinent for cell scale model. It is naturally designed to study the impact of individual
properties on populations. This is an enormous advantage to communicate with people
from other disciplines. For instance, in biology, this is particularly useful when the ques-
tion is to relate one single modification (in genotype or phenotype) in individual cell to
the full population, which is an important aspect in cancer research.
The model is not the final aim, outputs are. The easiness with which a model can be
exchanged, modified and simulated is important in the choice of the model type. Unfortu-
nately, nothing comes for free and there is a price to pay for ABM. To be able to simulate
properly a phenomenon, agent properties and interactions have to be known and modeled
in detail. The more specific the situation is to simulate the more has to be included in
the model. For instance, a simple model of cell motion needs a lot of information: model
for the cell surface, cell deformation, cell/cell friction, etc. Comparatively, continuum
approach would mean everything into a couple of equations. Other difficulties encoun-
tered by agent-based modelers are the time to program a valid simulator and in the case
of a large number of agents the simulation time and its CPU time consumption. Coding
optimization and using costly computer resources consumes a large part of the time (some
figures about this issue are presented in the next chapter). Despite these aspects, the cost
in time, in money and definitely in animal lives remains usually and easily under the cost
of experiments.
Once the choice to use ABM is made, a wide range of possibilities is still available for
the modeler. We distinguish two main families that cell-based model may belong to de-
pending on: (i) if cell morphology is modeled, most of the time by sub-cellular elements
and (ii) if agent are lattice-free or not, i.e. if model elements can move continuously or dis-
cretely in space. For further readings on the different models, see [20] and more recently
[47] 1. Every combination exists with its advantages and drawbacks, for instance Pott’s
models [34] include the morphology of the cell on lattice sites while [17] use deformable
particles to off-lattice cells. Precise morphology description of the cell is useful if one is
interested in cell sorting, whereas off-lattice model are practical to model physical forces
among the agents [25]. For the latter reason and the liver model requirements, our model
evolved naturally toward an off-lattice model at which we added an important mechanism
for liver cells: we refined the cell morphology that is represented by two objects during
the mitosis phase – when the cell divides. Moreover, we based our choice on validation
in vitro in [44] and especially in vivo in the liver in [43].
1The authors of [47] summarized different cell-based models. A correction needs to be done on their
review: cell-based Langevin dynamics does give access to biomechanics behavior. It is precisely the purpose
of this model type as it will be shown later
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1.1.2 Physical and mathematical model description
In brief:
We present here the assumptions that led to the physical and mathematical framework
of the model. We describe the cell shape, motion, growth and death control, interaction
with other cells, active movement, angular momentum and molecular transport.
Cell shape
In the model, a cell is represented by either a sphere or two spheres when it is in the
mitosis phase (the dividing phase). We call each sphere of the dividing cell a sub-element,
which gives to the cell a dumb-bell like shape. Each cell is assumed to be spherical after
division with diameter L. To grow, a cell first doubles its volume (linearly in time) and
then deforms into a dumb-bell during the mitosis phase. As the distance between the two
parts of the dumb-bell increases, the radius of each sub-element decreases. Finally, the
dumb-bell splits into two distinct cells with diameter L (see schematic illustration 1.1).
This makes the model hybrid between a purely cell-based model and a subcellular-based
model where the cell can really adopt different shapes. Here with two sub-elements during
the mitosis, the cell is not symmetric. This imposes to define the initial axis of division.
In the applications, this choice appeared to be crucial to determine tissue organization.
In the case of apoptosis, a special type of cell death (see below), a cell receives a signal
and commits suicide rapidly compared to the cell-cycle duration. In about 30 minutes,
the cell radius decreases to one third of the normal cell radius to become a so-called
apoptotic core that is removed later. The model includes apoptosis, which needs additional
parameters: apoptosis duration, removal duration, apoptotic core radius.
Cell growth and death control
In the model, each cell possesses its own cell cycle duration – the time needed by the cells
to grow and divide. The cell-cycle duration is a random number selected with a Gaussian
distribution probability around the biological mean value (generally cells divide in about
24 hours). This choice is justified by experiments where cell proliferation is desynchro-
nized after few divisions. Cells have the ability to feel their environment through their
cytoskeleton [45] and control their proliferation rates respect to the pressure they undergo
on their surface. Experiments by [40] suggest that cells can be triggered to enter cell cycle
arrest by external pressure. The model includes this cell capability. The cell decision to
divide depends on the pressure exerted on the cell surface. In our model, we mainly mod-
eled this dependency with pressure checkpoints rather than with nutrient control (liver is
very well vascularized, so we assumed no nutrient limitation in this environment). Cell
pressure is compared to a threshold value. If the cell pressure is less than this value then
the cell enters its cell-cycle and starts to divide. Different functions and inputs can be used
for instance in 3.2, the decision depends on regulatory factors. Figure 1.2 is the schematic
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Figure 1.1: Division process: illustration of the cell division algorithm. A cell maintains
its spherical shape during the first phase of the growth. During the mitosis, the sphere
deforms into a dumb-bell to finally splits in two cells.
Figure 1.2: Growth control: We mainly used this growth control. After division, the cell
is quiescent. Depending on the local pressure. The cell decides its cell-cycle entrance. If
the pressure is too high, it could enter apoptosis.
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illustration of the model used in liver applications. A cell can start to grow only if its pres-
sure is below a certain threshold and can die (undergoes apoptosis, in biological denomi-
nation for this type of death, necrosis is not modeled) only if the pressure is above a cer-
tain threshold. These thresholds are called respectively biomechanical force for inhibition
(BFI) and biomechanical force for apoptosis (BFA) (see pressure computation 1.1.3)When
the cell shape is a dumb-bell: the pressure is the sum of the pressure exerted by external
bodies on both sub-elements. We tested two models for the pressure measurement: we
sum the positive pressure or positive and negative pressure (due to adhesion).
Cell Motion
As each cell is modeled individually, the motion is represented by a system of equations,
one for each cell. When the cell is in a division process (dumb-bell shape represented by
2 spheres), the cell movement is driven by the sum of the forces on its two spherical sub-
elements. When cells are not in a division process (spherical shape), the cell movement
is driven by one sub-element. The sub-element movement indexed i is summarized in the
following Langevin equation:
Mi
dvi
dt
+Γ
cs
Acsi
Ai
vi+∑
j
Γ
cc
Ai j
Ai
(v
i j
i − vi jj )+ γcs
r
Ωi =
∫ t
0
Km(t− t ′)v(t ′)dt ′+∑
j
F i j+F
active
i
(1.1)
• Notation: underlined variables denote vectors, double underlined denote tensors,
scalar variables are not underlined. Subscript or superscript index i or j allways
refer to cell i or j.
• vi is the speed of cell i, Mi its mass and so the term Mi
dvi
dt
is the cell inertia.
• Γ
cs
is the friction tensor with the medium
• Γ
cc
is the cell-cell friction tensor.
• Γ
cs
Acsi
Ai
vi is the cell friction force with the medium.
Acsi
Ai
the contact area fraction of
the cell with the substrate.
• ∑ j Γcc
Ai j
Ai
(v
i j
i −vi jj ) is the cell/cell friction force where vi ji = vi+Ωi×ri ji denotes the
velocity of the cell i at the contact point between cells i and j, r
i j
i the vector from
the center of mass of cell i to the contact area between cells i and j.
• γcs
r
Ωi is the angular momentum.
•
∫ t
0Km(t− t ′)v(t ′)dt ′ is a memory term on individual history.
• ∑ jF i j is the sum of pairwise forces with other cells.
• F activei is a random force that mimics the active cell movement.
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This equation can be simplified with the following assumptions:
• Inertia term: Mi
dvi
dt
can be neglected because the movement is dominated by friction.
• We drop the memory term:
∫ t
0Km(t − t ′)v(t ′)dt ′ because time scale is large com-
pared to cell speed memory.
The equation becomes:
Γ
cs
Acsi
Ai
vi+∑
j
Γ
cc
Ai j
Ai
(v
i j
i − vi jj )+ γcs
r
Ωi = ∑
j
F i j+F
active
i
We assume the substrate to be a homogeneous and isotropic viscous medium, which
leads to take for cell-substrate (or sub-element/substrate) friction the Stokes equation for
spheres (see [18, 21]): Γ
cs
= (6piη0ri)I where I is the unit tensor, ri the sub-element radius
and η0 is the medium viscosity.
Cell-cell interaction
In [14], the authors show that attraction and repulsion between two cells can be modeled
by an interaction energy Vi j taken from the Johnson-Kendall-Roberts (JKR) model [49]
if the cytoskeleton is not disrupted – i.e. for small cell deformation. The JKR model de-
scribes the pairwise interaction between homogeneous isotropic elastic adhesive spheres
(see review in [6]) and it takes into account hysteresis. Indeed, cell contact history is im-
portant. Once cells are in contact, it requires energy to detach them from each other (see
figure 1.3 and 1.4). Thus:
”The JKR model directly includes adhesion and relates the contact area
to the elastic material properties and adhesion strength.” [43]
Let’s call FJKRi j the JKR force between cells i and j. We denote di j the distance be-
tween the centers of i and j. Ri, R j, Ei, E j,νi and ν j, the respective radius, Young moduli
and Poisson ratio of the cells. γ is a parameter that represents the adhesion strength. If
γ = 0, the force can only be repulsive and is exactly the Hertz model [56]. We denotes
δ = Ri+R j−di j, 1Ri j =
1
Ri
+ 1
R j
, 1
Ei j
= 3
4
(
1−ν2i
Ei
+
1−ν2i
E j
)
. Finally, the JKR force is implic-
itly given by the following relations:
δ =
a2
Ri j
−
√
16piγa
3Ei j
(1.2)
a3 =
2Ri j
Ei j
(
FJKRi j +3piγRi j+
√
6piγRi jF
JKR
i j +(3piγRi j)
2
)
(1.3)
Remarks:
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Figure 1.3: JKR force: Herzt and JKR force are qualitatively equivalent for elastic bodies
in contact. JKR force models the adhesion and the histeresis effect. When bodies touch
each other they adhere to each other (JKR contact path). Once in contact, the rupture
of the adhesion occurs at a distance greater than the contact distance. This mimics the
histeresis effect and relies on the contact history of the two adhesive elastic bodies.
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Figure 1.4: JKR force: (a) Two isolated cells have no interactions. (b) When they touch
each other, they form spontaneously adhesive bonds, which results in an attractive force.
(c) If cells are too close, the response is a repulsive force. (d) Once in contact, cells need
to disrupt the bonds to detach, even if the distance among the two cell centers is greater
than the sum of their radii.
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• Blood vessels are modeled like connected cells. The interaction among these cells
contains an additional elastic force: Felastici j = k(di j − d0i j) where k is the elastic
coefficient of the force, di j the distance between the two elements and d
0
i j the relaxed
distance.
• The Young modulus of the vessel network is given by E = k
2pir where k is the elastic
coefficient and r the radius of the sinusoid.
• During the mitosis, a sub-element can be in contact with 2 sub-elements of the same
cell. In this case, the interaction force is modulated with respect to the sub-element
positions.
Active cell movement
For the active movement F activei , we tested two different options. The uniformly distributed
random movement for spherical objects :
F activei =
√
2γ2Dη
i
(t) (1.4)
And in case of a pressure gradient, the active movement is also for spherical objects:
F activei = (1−Θ[∇piη i])
√
2γ2Dη
i
(t) (1.5)
p
i
is the pressure of the cell i. η
i
(t) active random movement of cell i: typically a
vector of a white noise in 3D. Θ(x) = 1 if x ≥ 0 and becomes 0 otherwise (Heaviside
function).
This second active force model takes into account the propensity for cells to move
toward areas where the pressure is lower.
Cell surface of adhesion
Cell surface can be fully adhesive or only partially. In the latter case, the cell polarity is
defined by a vector and an angle. The cell adhesive surface is defined by the intersection
of the cell surface and the circular cones given by the vector and the angle. A cell adheres
to another cell only if their two respective adhesive surfaces are in contact (see illustration
1.5). For dumb-bell cells, each sub-element has a polarity vector and a polarity angle.
A cell adheres to a dividing cell if the adhesive surface of the cell is in contact with the
adhesive surface of the closest sub-element of the dividing cell.
Angular momentum
The equation of the angular momentum Ωi of cell i is given by [21]:
γcs
r
Ωi =−γcc
r
∑
j
r
i j
i × (vi jj − vi ji )+
ai
2
aˆi× (F(1)i −F(2)i )+ τˆξi (1.6)
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(a) 2 polar cells adhering to each other on their
adhesive poles in contact.
(b) 2 polar cells not adhering, cells are in contact
but not their adhesive poles.
Figure 1.5: Illustration of anisotropic cells. The green on the surface cell is the adhesive
area of the cells. It is defined by 2 cones at each pole. A cell can adhere to another one
only if both adhesive surfaces are in contact.
• γcs
r
Ωi denotes the friction of cell i with the substrate due to its rotation.
• −γcc
r
∑ j r
i j
i × (vi jj − vi ji ) denotes the cell-cell friction due to the rotation.
• ai
2
aˆi× (F(1)i −F(2)i ) external torque on the cell i where F(1)i and F(2)i are the forces
that act on the dumb-bell system (on the center of each spherical sub-element), ai
the length of the dumb-bell axis and aˆi the unit vector of this axis.
• τˆ
ξ
i is a random fluctuating torque.
We simplified with those assumptions:
• We started with the deterministic case and drop the random fluctuating torque τˆ
ξ
i ,
the active movement F activei induces enough randomness in the system to relax it and
to remove artificial situations.
• When cells are not polar, we don’t consider cell rotation movement. When they are
polar with use the metropolis algorithm of [22].
The equation becomes:
γcs
r
Ωi =
ai
2
aˆi× (F(1)i −F(2)i )
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Molecular transport and diffusion
For some model applications, we have to couple biomechanics with local molecular con-
centration.
Linear and exponential approximation: (for sinusoid morphogen attraction, see
section 3.1.4) Chemoattraction – the cell movement toward high chemoattractant concen-
tration – is represented by an additional active force in the Langevin Equation: Fchemoattractioni =
χ∇c(x, t) where the function c(x, t) is the molecule concentration at time t and at location
x. We approximate the chemoattractant diffusion and consumption by a linear function
(this approximation has been done for oxygen in [58]) or by an exponential function (ex-
act solution in 1 dimension). The concentration is maximum at source location and 0
when distance is higher than the morphogen range.
Cell/Cell transport(for Wnt and GF, see section 3.2) To consider cell/cell molecule
transport, we used an osmotic model of diffusion, which mimics the molecular exchanges
from cell to cell via the surface contact of cell membranes with respect to the cell volume
concentration. We assume homogenous concentration in cells, fixed cell volume, contact
surfaces and distances at time t. The concentration is given by :
dci(t)
dt
=
D
Vi
∑
j∈N(i)
si j(c j(t)− ci(t))
di j
(1.7)
where N(i) is the set of indexed neighbors of cell i, si j the contact surface between cell
i and cell j, Vi the volume of cell i, D the coefficient of diffusion for the considered
molecule, di j the distance among cell i and cell j.
In case of fixed cells and full space discretization, equation 1.7 is the finite volume
discretization used to solve the classic equation of diffusion:
∂c(x, t)
∂ t
= D∆c(x, t) (1.8)
Cells follow the Langevin equation of motion and grow, so volumes, positions and contact
surfaces evolve in time.
1.1.3 Measures available
As explained above, agent-based models provide a practical framework to include and
extract data. The model gives access to all individual values of cells at any point in time,
which is not possible in experiments. It is also possible to average individual values over
several agents to obtain other observables. To understand the figure results, we listed
below the available measures in the model.
Cell number
The cell number is accessible at all time points. It is also possible to specify the cell type
or properties: tumorous, active, quiescent, apoptotic, etc.
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Pressure
Two models of pressure computation have been used. Pressure P equals either the sum of
forces exerted by cells in contact on the cell (equation 1.9) or the sum of positive forces
exerted by cell in contact on the cell (equation 1.10), divided by contact surface between
cells.
P= Σ j
FJKRi j
Ai j
(1.9)
P= Σ j
max(0,FJKRi j )
Ai j
(1.10)
Contact area
The contact area among element model is computed thanks to space discretization. The
domain space is discretized in a cubic and regular grid. Each cube that intersects with a
cell is labeled by the cell index. Then, each cube face that separates two distinct elements
(different cell index) can be counted. Thus, the model can measure the surface contact
between healthy cells/ tumor cells, healthy cells / endothelial cell, tumor cells / endothelial
cells, etc. To avoid units issues, the contact areas are divided by the total element surface
in contact and presented as a dimensionless contact area fraction.
Densities
Biological information is commonly given as density. The model can relate the spatial
element to a density by counting the number of elements on a discretized space. In the
results sections, endothelial cells density is shown. The model can provide data in 3D or
2D (with projection on a plane) and delivers density of apoptotic cells, quiescent cells,
tumor cells, proliferative cells, etc.
Blood vessel data
The nodes that constitute the endothelial cells (cells that form the blood vessels) are mod-
eled as an elastic graph. From the position of each node and its connected nodes, we
can establish the mean distance among nodes and also the mean angle (most of the time,
the nodes are connected only twice). The mean node distance and mean angles are two
measures for the distortion of the graph.
Radius of gyration
For cell populations, the radius of gyration Rg is a value that gives information on the
object size and shape. This value is computed by giving a weight to each cell with respect
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to the distance to the cell population center of mass. It is given by:
Rg =
√
1
N
∑
i
((xi− xcm)2+(yi− ycm)2+(zi− zcm)2) (1.11)
where xcm =
1
N ∑i xi, ycm =
1
N ∑i yi and zcm =
1
N ∑i zi are the coordinates of center of mass.
Principal component analysis
Let M be the cell population covariance matrix.
M =

 ∑i(xi− xcm)2 ∑i(yi− ycm)(xi− xcm) ∑i(zi− zcm)(xi− xcm)∑i(xi− xcm)(yi− ycm) ∑i(yi− ycm)2 ∑i(zi− zcm)(yi− ycm)
∑i(xi− xcm)(zi− zcm) ∑i(yi− ycm)(zi− zcm) ∑i(zi− zcm)2

 (1.12)
where xcm,ycm,zcm are the coordinates of the cell population’s center of mass and xi,y,zi
the coordinates of cell i.
In 3D, the principal component analysis consists in finding eigenvalues of the covari-
ance matrixM. Each value is the size of the axis in a coordinate system, chosen such that
the longest axis of the object of cell population is the first eigenvalue; the other ones are
orthogonal to this axis. In case of compact cell populations, the principal component anal-
ysis is a key value to analyze the results. It gives the symmetry of the cell population. A
spherical population pattern has equal eigenvalues whereas elongated population patterns
have at least one greater eigenvalue.
Evolving pattern
During the computation, because each cell position is known, it is possible to observe cell
population’s shape. Regularly, the model outputs all positions in a file. The cell population
can then be visualized thanks to the visualization tool implemented and described in the
next section.
Conclusion:
The developed model takes place in the realm of systems biology research, a relatively
recent domain of science. It approaches problems like experimental science does, but
in contrast to which the experiments are conducted in computer software. In many
contexts and in biology especially, agent-based models are good candidates for this
type of modeling. They provide a direct approach in which all individual information
is immediately available. Finally, by approximating the cell as dumb-bell and including
biomechanics in the model, the elements follow this equation of motion:
(6piη0ri)
(
Acsi
Ai
vi+
ai
2
aˆi× (F(1)i −F(2)i )
)
+∑
j
Γ
cc
Ai j
Ai
(v
i j
i − vi jj ) = ∑
j
F
i j
jkr+F
active
i
(1.13)
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Chapter 2
Implementation of the simulator
In brief:
In this chapter, we describe algorithms and necessary components to simulate the agent-
based model presented in the previous chapter. Due to the complexity of the prob-
lem, many challenges had to be faced and the implementation occupied a large part
of the working time. Technical descriptions are developed here in order to be repro-
ducible: program language, libraries, algorithms, numerical schemes, parallelization
and solvers. We show benchmarks that compare program efficiency of the sequential
version to the parallel version.
2.1 Introduction
The model is based on the framework of [22], but the complexity turned out to be far
beyond the simulation tool to model monolayers and multi-cellular spheroids, and more
complex than the model tool used for liver regeneration [43]. Moreover, in a number of
simulations the tumor cells were strongly compressed against the blood vessels, which
yields very large forces. In order to guarantee numerical stability, the time step had to
be significantly reduced, which led to very long simulation times. Significant effort was
spent for making the simulator faster, more flexible and more robust. This led to a better
modularity of the code and about 5-times shorter simulation times than the first version
of the code. A large number of independent tests had to be performed to guarantee a high
reliability. The whole code is 50,000 lines large. The development time represents about
two third of the total worked time. We present in this chapter the main algorithms and
libraries used to simulate the model.
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2.2 Description of the components of the code
In brief:
The choice of the programming language was guided by our needs, which are:
• Modularity: the model should be open to extensions without a full re-
organization of the code.
• Collaborative: the code should be readable and understandable rapidly by col-
laborators.
• Fast: the simulations deal with a large number of elements. The program must
be fast enough (optimized compilers, optimized algorithms).
• Robustness: A debugging method should be applicable on the code to ensure a
minimum of implementation error.
2.2.1 An adapted programming language for agent-basedmodel: C++
C++ is a programming language born at the end of the 70’s. Bjarne Stroustrup, its creator,
made it up first to enhance with classes the very fast and robust programming language
C[74]. The purpose was to make C, an object-oriented language. Later, many other fea-
tures have been added to C++, which make this programming language still alive and
evolving (last release was delivered in september 2011). During the last decades, C++
became a very popular language. Thanks to the Internet development, many communities
used and ask to the C++ committee to improve the language. In particular, many libraries
of functions where developed for free and tested by an international community (boost
library for instance). This success is due to the great performance of C++ (much faster
than java, a language that offers approximately the same possibilities) and its modularity.
Indeed, oriented-object languages are conceptually thought to be modular. It is possi-
ble to program independent building blocks and integrate them in the code [26]. This
modularity is appreciated in collaborative work and open problems that are constantly
evolving – like it is in scientific research. Moreover, application to individual based mod-
els is straightforward to translate in object-oriented programming language. The program
was developed in order to serve different mathematical models based on the same model
framework. For this purpose, the generic programming possibility is useful if one wants to
use classes with different objects. We make here a general remark on imperative program-
ming language: the object structure is very good to split and cut and apply reductionism
paradigm to the implementation. The implementation of the interactions between agents
is not solved anyway. Algorithms have to be well defined and ordered to be properly im-
plemented. Relations among the object are the difficult part (in particular, discretizing and
sorting the interactions). Finally, as C++ is very popular, it comes with many graphical
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Figure 2.1: Screenshot of the Graphical user interface with OpenGl real time visualization
user interface (GUI) libraries. We chose Qt library for its large number of functions and
its complete documentation (figure 2.1). Based on our constraints and C++ capabilities,
C++ programming language was the best candidate to code a simulator.
2.2.2 Visualization with OpenGL library and POVRAY
Visualization is one of the most useful measures in simulations for programmers to debug.
On the contrary, the modeler must not rely on visualization. Figures and curves only may
prove that simulations are correct but their ability to stimulate intuition is not as efficient
than visualization. Moreover, images can be directly compared to experimental images
and this issue is crucial in biology. This is why it has been necessary to produce images
and movies from our simulations. The software includes a 3D real time visualization
of the simulations that has been coded with OpenGL library. The simulator outputs are
processed and can produce 3D visualization as well. For this post-processing, the ray
tracer POVRAY was chosen. The image quality plus the interface close to C language
easy to understand for programmers imposed us this choice. The software developed for
the model integrates a module that converts model data to POVRAY data format. As an
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Core number Code description Gain % of parallelization
1 (1): Model with no cell-cell friction
12 (1) 2.5 67%
12 (2): (1) + parallelization of contact detection 2.92 73%
1 (2) in Liver
12 (2) 4.92 88%
1 (3): (2) + cell/cell friction
12 (3) 2.31 63%
12 (4): (3) + matrix assembly parallel 2.29 62%
12 (5): (4) + sparse matrix multiplication in parallel 2.40 65%
12 (5) + conjugate gradient parallel 3.18 76%
Table 2.1: Benchmarks of parallelized portion of the code
example, all images from the model in this document have been obtained with POVRAY.
2.2.3 OpenMP
New machines offer multiple cores CPU and/or multiple CPUs. We took advantage of it
with library OpenMP® included in last GNU C++ compilers. The use of this library is
simple. The purpose is to compute at the same time in different cores with a shared mem-
ory. The temptation to parallelize the computation is high because the shared memory
does not copy data to pass it to other computation units. Shared memory parallelization
needs carefulness. The main advantage of the shared memory is also its immediate draw-
back while it is possible to write and read at the same memory location with different
threads leading to memory errors and program failure. OpenMP® library provide an easy
method to distribute the computation over the cores during the loops. Most of the com-
putations are made with loops over the elements of the system. In a 10 cores machine,
this should allow a 10 times faster computation. Unfortunately, this optimal case is rarely
reached because of element dependency. Furthermore, some parts cannot be fully paral-
lelized. For instance, updating a list by swapping, adding or removing elements is not an
operation that can be fully separated in different threads without copying data. The best
here is to make a list by threads with elements that are to be modified and then scan the
resulting lists to apply the modifications. The additional cost could make unfruitful the
parallelization.
The computation speed is dependent on the number of objects and their types. In table
2.2.3, we present some benchmarks that show the efficiency of the parallelization. % of
parallelization is 100
G−1 , G is the gain in computation time, and represents the fraction of
the code that is computed in parallel.
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2.2.4 Debugging protocol
The complexity of the program needed to apply a strict debugging protocol. The code
can be compiled in debug mode or in release mode. The two versions coexist. Each
parallel algorithm is sequentially coded and during debug mode execution, the results of
each parallel algorithm is compared to its sequential version. For optimized algorithm we
proceed the same way. The greedy version, usually easier to implement and containing
less bugs, is coded and compared to the optimized one to ensure that the results are correct.
Furthermore, the memory checker Valgrind was used to check any leak of memory after
each important modification of the code. When it was not possible to find the origin of
the bug,we used a full debugger called GDB. Finally, we tested the simulator in simple
cases to check the behavior of the model.
2.2.5 Diffusion of the code
Today, the code is applied to different model variants. Coding variants allow programmers
to make evolve the code by adding new functions and to find unsuspected mistakes. In
particular, new cases that were not tested are explored. A program with no bugs is a pro-
gram with no users. Thanks to collaborations, (3 partners are using the present described
source) the code evolved and became more robust. The different applications are briefly
presented in the Appendix 4.2.
2.2.6 Automatization and Monitoring
The model requires testing many parameters and assumptions. This sensitivity analysis
produces a lot of results. The large number of simulations to perform prevents to rely
on human control of the whole process that introduces to many mistakes. To minimize
the mistake introduction, we automatized the workflow. The process chain is automatized
such that the modelers need only to choose the parameters and options of the simulation.
This is performed with two shell scripts.
Shell script process: Compile/Run/Post-Process
1. Edit a configuration file with macros.
2. Compile the code with proper options and files (only compile the files associated to
the chosen model to minimize the compilation time).
3. If the compilation finished: copy sources, configuration and initial file to folder.
4. Run the program with parameters (duration, iteration number, simulation name,
initial file path).
5. While the program is running and producing outputs, they are processed and stored
(descriptive latex file, curves with Gnuplot, images with Povray and movies).
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Figure 2.2: Screenshot of the web page where results are automatically sends. A brief
summary of information is presented: cell number, tumor cell number, last image pro-
cessed, running time, etc.
6. The last image and curve processed are sent to the server open to the web with some
additional information (cell number, tumor cell number, percentage of the duration
accomplished).
The first script allows to choose in a text file the defined macro (corresponding model
assumptions listed in Appendix 5.3) and parameters that will be used in the simulation.
This method saves running time because the model options only are compiled. Other op-
tions do not exist in the final executable and so the program does not need to evaluate
the different possibilities during the execution. In addition, each user has its own config-
uration file and can compile the code with its usual options without risking compilation
conflicts with other users functions.
The second script is a loop that scans all simulation outputs and processes the result.
It compiles the program with backup sources and translates the output files into curves
(with GnuPlot), images with POVRAY and movies (FFMPEG concatenate the images).
Each image is sent to a web server. A web page has been designed to show progression
of the simulation in real time (figure 2.2).
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Conclusion:
C++ is an appropriate programming language choice because of :
• Many libraries (especially parallel programming, graphic library and user inter-
face)
• Quite low level language, speed of execution
• Modularity (for different problems and collective work)s
• Popularity (students, collaborators often know this language and it is easy to find
documentation)
• For agent-based modeling: object-oriented, inheritance, generic programming
• Parallelization with OpenMP included library in GNU C++ compiler.
• A large choice of debugging tools exist for C++ code.
2.3 Numerical methods and algorithms
In brief:
The aims of the simulator are to compute equation (4.1) with an initial input and to
output and analyze the results. In this section, we present selected algorithms and nu-
merical methods we used to compute the Langevin equation: numeral issues, numerical
schemes, main algorithm, parallel sparse matrix solver and parallel contact detection.
Many functions that simulate or analyze the model are too trivial and can be straight-
forward programmed even though the time to include them in a code can be long.
The computation of the system of Langevin equations (4.1) is made in two steps.
In computers, continuum does not exist so the continuum equations need at first to be
discretized in time and space. Then each of equations component has to be computed to
actually solve the equation.
Explicit Langevin discretization
Generally, implicit numerical schemes are more stable and allow taking bigger time step
than explicit schemes. In our case, the implicit discretization is not possible because of the
Johnson-Kendall-Roberts (JKR) force. Indeed, JKR force is not given by the derivative of
a potential but directly as a force. This does not help to define the variational problem if
one wants to solve the numerical schemes with finite elements for instance. Moreover, it
is implicitly defined (equations (1.2) and (1.3)). In spite of these two reasons, it is possible
to define numerically a JKR potential. Finally, the real obstacle that prevents the use of
40 CHAPTER 2. IMPLEMENTATION OF THE SIMULATOR
an implicit scheme is that it is impossible to know the elements in contact for future time.
Without this information, it is not possible to derive forces acting in the system.
We rewrite equation (4.1) for element i, with velocity vi, vi j = v j− vi, α the medium
friction, βi j is the cell-cell friction, e vector from cell i-th to cell j-th center, fi sum of the
forces but frictions on cell i (NB. βi j is surface dependent βi j = β
Ai j
Ai
and βi j 6= β ji). The
explicit Langevin discretization for each element is:
αvni = ∑
j
(β ni j(v
n
i j− eni j(vni j · eni j)))+ f ni (2.1)
where upper-script n denotes that the term is computed at time point n where the
system state is known, vni =
xn+1−xn
dt
, xn is the position of element i at time n and dt the
time step. Thus, vni permits to compute x
n+1
i , the new position of the element.
Time step issue
We are not able to prove the stability of these explicit schemes due to non-linearties and
complications introduced by the cell growth, division, death and hysteresis. However, we
define the time step with a hard condition that prevents numerical errors. Indeed, for each
iteration we look for the time step value that ensures that:
1. collision between elements well captured.
2. adhesion ruptures cannot be artificially induced.
For case 1, the time step dt is accepted if dt ≤ 1
3
mini(
min j(di j)
vi
). This condition guar-
antees that no element will be closer than one third of its closest element. For instance, at
time tn, if two elements attract each other, at time tn+1 = tn+dt, the force among the el-
ements is evaluated again. If elements are too close from each other (collision), the force
becomes repulsive; else elements are still attracted but again cannot move to be closer
than one third of their distance. Thus, the algorithm will not miss their collision. For case
2, the principle is the same but applied on the adhesion rupture distance.
The simulations of stiff blood vessels turned out to be very long despite parallelization
of the code, particularly if the vessel Young modulus is chosen to be 1000 Pascal or larger,
which corresponds to realistic values. Indeed, the vessel nodes are very close to each other
and their velocity depends on the elastic force among them. Large forces necessarily
decrease the time step and in the case of vessel stiffness this relation is linear.
Adapted time steps can induce oscillations between elements in contact. The time step
is chosen to be maximal (under the condition mentioned above) and elements could move
around their equilibrium position (when it exists). This effect is smoothed out when the
number of element is large. However, to avoid this artificial effect and large time step
variations, dt is taken close to the mean value of the time steps. If (dt ≤< dt >)dt := dt
else dt := <dt>+dt
2
) where < dt >= 1
N
ΣNn dtn the mean dt value over the iterations.
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Figure 2.3: Number of cells respect to time in a non spatial model. The two curves are
produced by the same code. The red curve used a simple precision for real numbers (float),
the green curves used a double precision (double). The cell population doubles every unit
of time. The tow curves are progressively desynchronized is due to the truncation error.
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Truncation error
Discretization of space is not needed to solve the Langevin equation and the model agents
can freely move in space. Notwithstanding computers cannot compute with real num-
bers and a ”discretization” is hidden somewhere. Indeed, real numbers are truncated at a
certain order of precision (in computers, it correspond to the number of bits used). This
truncation can create serious artifact. For instance, for a simple non-spatial model of cell
division, if the precision is insufficient, the cell division is delayed (see figure 2.3) and
results do not correspond to the model.
2.3.1 Solving cell-cell friction
In 2.1, each vni depends on other velocities. The computation of the element velocity needs
to solve a system. For two elements, with omitting the time n and assuming same size
object for simplicity β = βi j = β ji, the system to solve is:{
αvi=β (vi j− ei j(vi j · ei j))+ fi
αv j=β (v ji− e ji(v ji · e ji))+ f j (2.2)
Let u be the speed of cell i and v speed of cell j, the full developed example with 2 cells
becomes:


(α +β (1− e2x))ux+β (e2x−1)vx+βexeyvy−βexeyuy+βexezvz−βexezuz= f ix
(α +β (1− e2y))uy+β (e2y−1)vy+βexeyvx−βexeyux+βeyezvz−βeyezuz= f iy
(α +β (1− e2z ))uz+β (e2z −1)vz+βezeyvy−βezeyuy+βexezvx−βexezux= f iz
(α +β (1− e2x))vx+β (e2x−1)ux+βexeyuy−βexeyvy+βexezuz−βexezvz= f jx
(α +β (1− e2y))vy+β (e2y−1)uy+βexeyux−βexeyvx+βeyezuz−βeyezvz= f jy
(α +β (1− e2z ))vz+β (e2z −1)uz+βezeyuy−βezeyvy+βexezux−βexezvx= f jz
(2.3)
The matrix form of equation 2.3 with γx = β (1− e2x), γy = β (1− e2y), γz = β (1− e2z ),
βx,y = βexey, βx,z = βexez and βy,z = βeyez is:


(α + γx) −βx,y −βx,z −γx βx,y βx,z
−βx,y (α + γy) −βy,z βx,y −γy βy,z
−βx,z −βy,z (α + γz) βx,z βy,z −γz
−γx βx,y βx,z (α + γx) −βx,y −βx,z
βx,y −γy βy,z −βx,y (α + γy) −βy,z
βx,z βy,z −γz −βx,z −βy,z (α + γz)




ux
uy
uz
vx
vy
vz


=


f ix
f iy
f iz
f
j
x
f
j
y
f
j
z


Let matrix Ai j be :
Ai j =

 −γx βx,y βx,zβx,y −γy βy,z
βx,z βy,z −γz


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For a system of 4 elements, where element 1 interacts with 2 and 4, element 2 interact
with 1 only, element 3 has no interaction and element 4 interacts with 1 only.


αI3−A1,2−A1,4 11,2 0 A1,4
A1,2 αI3−A1,2 0 0
0 0 αI3 0
A1,4 0 0 αI3−A1,4




u1
u2
u3
u4

=


f1
f2
f3
f4


This example shows that as the number of element increases, the sparsity of the matrix
increases too. In 3 dimensions, the average number of neighbors for an element is 12. In
our common application the non zero values represent only 0.001% of the total matrix. We
used this sparsity to store the matrix. Indeed, the matrix size for N elements is 3NN that
prevents the full storage of the matrix in computer memory. We build up a special class to
store symmetric sparse matrix and to solve in parallel the linear system Ax = b (A is the
sparse matrix, b the force known force vector and x the unknown vector of velocities. We
used the symmetric Compressed Storage Column (CSC) matrix format [32] (see example
with equivalent format Compressed Storage Row (CSR) 2.4). The matrix is assembled
on the fly during the contact detection. We solve the system with the conjugate gradient
method, an iterative method where the matrix vector multiplication and the sums over
elements are parallelized. To debug, we use the Cholesky direct method and we compare
the results [70].
2.3.2 Main algorithm
The main algorithm is called to simulate the model evolution. For each time step, it
computes the forces in the system and moves the elements with respect to these forces.
The time step is computed and adapted to be as large as possible. The time step value is
added to the total simulated time. The algorithm stops when the total time t is greater than
the prescribed duration T .
While t ≤ T :
1. initialize all sub-element: Reset the displacements, pressures, contact elements.
→ OpenMp optimized
2. compute hysteresis: Compute the forces among pairs of elements recorded in the
previous iteration. → OpenMp optimized
3. apply on each pair( compute cell/cell forces, compute cell/node forces ): Space is
discretized in a regular grid. Look for possible pairs of elements in contact (detail
in 2.3.3). If a contact is found, the force among elements of the pair is computed.
The pair is recorded for hysteresis effect. → OpenMp optimized
4. update cell polarity: Polarity is updated via the metropolis algorithm (detail in
[22]). → OpenMp optimized
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Figure 2.4: CSR format to store a sparse matrix. Let N be the dimension the matrix and m
the number of non-zero values of the matrix. The Row vector has then a size N+1 and the
Column vectors and Values a size m+1. For i from 1 to N+1, Row[i] stores the position
in the Values vector at which starts the storage of the non-zero values of the row i of the
matrix. Row[n+ 1] point at the last position of the Values vector. Thus, for j of Row[i]
to Row[i+ 1]− 1, Values[ j] corresponds to a non-zero value on the row i and Column[ j]
indicates the position of the corresponding column. Figure from Maya de Buhan.
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5. compute spring force: Compute the elastic force between nodes of the graph that
represents the vasculature. → OpenMp optimized
6. compute pressure gradient: Compute the pressure on a grid of cell densities to add
a bias in the random movement. → OpenMp half-optimized
7. solve friction: The friction matrix is assembled with each cell-cell contact detected
above in step 3. The inversion of the matrix is done with a parallel conjugate gradi-
ent. Details in Section 2.3.1. → OpenMp optimized
8. compute torque rotation: Compute the dumb-bell rotation. It sums up the asym-
metric forces on the dividing cells and computes the rotation. → OpenMp opti-
mized
9. compute random: Compute the cell random force and the adapted time step. The
time step is reduced in order not to miss collisions. It must be done after every
component of the movement has been actually computed.
10. compute diffusion: Set the source elements (it depends on their location, they could
have moved or changed), list every cell surface area.
11. Compute the adapted time step: Choose a mean time step to decrease large time
step variations that could create oscillations. Minimum of moves with random
adapted time step and diffusion adapted time step. adaptedTimestep(dt) = min(
maxTimeStep, 1.2×meanTimeStep ) → OpenMp optimized
12. Apply diffusion(dt): with respect to the adapted time step dt, update the concentra-
tion values in the cells.
13. Compute intracellular concentrations(dt): with respect to the adapted time step
dt, compute the values of the intracellular concentrations (ODE system)
14. update cell status(dt): with respect to the adapted dt. Kill, grow or divide cells.
This function is difficult to parallelize because the list of elements is modified. Sev-
eral threads could potentially write at the same memory location.
15. apply random move(dt): with respect to the adapted, actually add αη
√
dt, the
random movement, in each element. η is a gaussian distributed random vector, α
the amplitude of the movement. → OpenMp optimized
16. Link growth(dt): Increase the distance among nodes in the graph with respect to
the adapted time step. → OpenMp optimized
17. Node death: Destroy nodes that undergo too high pressure.
18. Move All(dt): Actually apply the computed move and change the position of all
elements. t → OpenMp optimized
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19. Update link length: Once the nodes have moved, the length of the edges of the
graph should be updated. → OpenMp optimized
20. Stretch growth: If the length of the links doubled, we add a node. → OpenMp
optimized
21. Update positions in map box: Update the list of elements in the grid used to detect
contact. → OpenMp optimized
22. t += adaptedTimestep: Increment total simulated time t
2.3.3 Parallel contact detection algorithm
In brief:
Contact detection algorithm is an example of an algorithm that cannot be parallelized
simply by splitting the loop over the elements in different threads. Because of its high
computational cost, the algorithm benefits of parallelization with few elements. We
implemented a generic class for contact detection in parallel.
The detection of the interactions depending on distance between objects (mainly con-
tact detection) occupies a large part of the computation. The most basic algorithm can
be straightforwardly implemented but has complexity in O(n2), n being the number of
elements, and makes the computation too slow even for few elements (algorithm 2.1)
Algorithm 2.1 Basic algorithm for contact detection. Each element has index (integer),
spatial coordinates x,y,z, radius r. Complexity is O(n2), the worst.
for element i= 1→ n−1 do
for element j = i+1→ n do
if (xi− x j)2+(yi− y j)2+(zi− z j)2 ≤ (ri+ r j)2 then
displacements i, j← f (i, j)
end if
end for
end for
In the model, objects have approximately the same size. Adapted algorithms for this
particular situation have been developed in order to find rapidly the interacting pairs [65,
66]. The principle is to discretize the domain in bounding boxes and to list the objects
in it. For spheres, we consider that an element is in a box if its center is actually in the
bounding box. The contact detection needs to check the distance among each pair of
objects. Elements of a box can be in contact with elements within the same box and/or
with elements in neighboring boxes. This routine has a complexity in O(m2) where m is
the number of objects in the box and surrounding boxes. That is why it is very important
to reduce as possible the number of objects in boxes. If elements are spherical, the best
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box size is the sphere diameter. This algorithm reduces immediately the complexity to
O(n)O(m). It seems to be the minimal complexity because the algorithm has to pass by
the list of all elements at least once algorithm (2.2).
Algorithm 2.2 Improved algorithm for contact detection with bounding boxes. Each
element has index (integer), spatial coordinates x,y,z, radius r. Complexity is O(n)O(m).
for element i= 1→ n do
b← box index of i
for element j ∈ b,→ m do ⊲ for each elements of box b and neighbors of box b
if (xi− x j)2+(yi− y j)2+(zi− z j)2 ≤ (ri+ r j)2 then
displacements i, j← f (i, j)
end if
end for
end for
It is possible to enhance this algorithm (algorithm 2.3). The loop is not made on each
element but on each box. The boxes are listed dynamically and so the number of boxes is
less or equal than the number of elements. The first advantage is that it allows skipping
finding the box index of each element. The most important advantage is that it permits
to look only on half of the neighboring boxes without missing any contact (see 2.5). In
dimension 3, this algorithm saves 13 loops with respect to the classical contact algorithm.
Algorithm 2.3 Algorithm for contact detection with bounding boxes and enhancement.
Each element has index (integer), spatial coordinates x,y,z, radius r. Complexity is
O(b)O(m2). The enhancement consists in looking directly in the boxes. It permits to
look only half of the neighbors and skip the step of finding box index of i.
for box b= 1→ nb do ⊲ loop over the boxes
for element i ∈ b,→ m do ⊲ for each elements of box b
for element j ∈ b and in half of neighbors do
if (xi− x j)2+(yi− y j)2+(zi− z j)2 ≤ (ri+ r j)2 then
displacements i, j← f (i, j)
end if
end for
end for
end for
Finally, with this modified form, the parallel computation of algorithm 2.3 is possible
and more accurate. OpenMP ® parallelization is more efficient on costly loops. Indeed,
the distribution of the computation over the different cores and threads has a certain fix
computational cost. In the contact detection algorithm, it is better to parallelize the upper
loop on boxes. Nevertheless, the splitting of the box list must ensure that 2 elements would
not be written at the same time by different threads. Here, the parallelization requires
additional information of the model: a contact cannot occur between objects separated by
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Figure 2.5: Sequential algorithm. For each element in each box, the distance between
elements in box and neighboring boxes is check to detect contacts.
more than one box. Thus, if even box indexes are computed in parallel, a thread for an
index, different threads cannot read/write on the same elements (see 2.6) and the same for
odd box indexes (algorithm 2.4).
Algorithm 2.4 Algorithm is the same than the sequential 2.3 but the loop over boxes is
parallelized.
for list of box with x index even, then list of box with x index odd do ⊲ Parallel loop
over boxes list.
for box b= 1 ∈ list→ nb do ⊲ loop over the boxes of the list
for element i ∈ b,→ m do ⊲ for each elements of box b
for element j ∈ b and in half of neighbors do
if (xi− x j)2+(yi− y j)2+(zi− z j)2 ≤ (ri+ r j)2 then
displacements i, j← f (i, j)
end if
end for
end for
end for
end for
For our model, we include additional features. Elements of the boxes are generic and
code with template classes, this is particularly useful to use this class for new models.
We create a dedicated and optimized data structure for the boxes for dynamic memory
allocation of elements and fast memory access. For the liver applications, we introduce
periodic domain. Boxes at the border are connected to the other border. It is especially
tricky for the parallel algorithm because the number of columns could be inappropriate.
For instance, if the number of threads is 5 and the number of column is 9, the last column
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Figure 2.6: Parallel algorithm. Each blue column is computed in a different thread. No
memory collision can occur between the different threads because they don’t treat the
same element. Once the contact detection of the elements of the blue box have been
checked, the algorithm computes in parallel the red column.
will be computed by thread 5 and the first by thread 1 at the same time. Threads at the
border could then cause memory collisions. To avoid this, the size of the boxes has to
be set such that the number of columns is adapted to the number of threads. Finally, we
implement a second type of elements. These elements are blind to their own kind but
interact to the first type of element.
Conclusion:
Model simulations are very demanding. They imply a large number of elements and
ask for numerical accuracy and rigorous conditions. A large part of the work is nec-
essarily invested in implementation and optimization. Efficient algorithms have been
created to work with recent techniques of parallelization and provide software able to
solve rigorously the model. We manage to create the first liver model able to analyze
multiple cancer phenotypes in 3D in a multi-lobule environment. Moreover, thanks to
the generic implementation, the code can be applied to other models.
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Chapter 3
Application to liver carcinogenesis
3.1 Introduction
In brief:
Despite the large efforts over the last decades, cancer is a leading cause of death. The
complexity of the disease has now led to request of support to the mathematical com-
munity [28]. Colnot et al. [15] have developed an interesting liver in vivo cancer
mouse model. The model could explain some aspects of the human liver cancer but
also pointed a number of questions. We adapted the model introduced in the previ-
ous chapters to address these questions by studying the possible influence of different
mechanisms on carcinogenesis by simulations with our in silico liver model. We detail
in this section the biological information necessary for this application, namely: the
liver cancer, the mouse model, its data and questions, and the model specificities that
we had to include to mimic possible scenarios of carcinogenesis in liver.
3.1.1 Some key figures about cancer
The most general cancer definition could be: “an abnormal cell proliferation caused by ge-
netic mutations”. In most cases, the proliferation of cancer cells has a monoclonal source
[36], which means that a single mutated cell initiates the cancer and the invasive clone is
composed of only one genotype. This cell is degenerated and, by either its proliferation,
its loss of functionality or both, it damages organs until they are not able to accomplish
their task anymore, which eventually causes death of the host. Often, the organism does
not fight against this aggression since it is not identified as a threat. Symptoms may be
often visible only at a very advanced stage of cancer development, which makes therapies
less effective and personalized treatments more favorable for cancer therapy [64, 80].
According to World Health Organization, cancer was responsible for 7.6 millions
cases of death in 2008, which makes cancer a leading cause of death worldwide (around
13% of all deaths). Among them liver cancer is the third most killing cancer with 695000
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deaths and the Hepatocellular carcinoma (HCC), variant of liver cancer, is involved in the
78% of them. Most of the time, HCC develops out of hepatitis or cirrhosis. For instance,
in France, the number of cases is constantly increasing 1 and generally, the number of
patients tripled between 1975 and 2005 in western countries 2. Obviously, the human
and economic impacts of this disease are important and have driven a large amount of
investments in research to cure liver cancer. International agency for research on can-
cer (IARC) has a budget of about 38 billions of dollars every 2 years. The new plan for
the fight against cancer in France amounts to 732 million euros for the 2009-2013, of
which 95 million are invested in research. The ARC alone spent 21 millions euros in the
last decade. In this context, every success in comprehension on HCC is valuable. How-
ever, despite the large progress accomplished, cancer remains a very difficult question.
Medicine and biology looked for contributions from every domain of science to tackle
this disease.
For this reason, mathematicians and computer scientists have been solicited and mod-
els start to emerge. Nowadays, models are more and more directly compared to biological
data. As an example, the reader can refer to [75] where the authors make predictions using
an in silico model. Along this spirit we here aim to contribute to the understanding of the
emergence of HCC, its initiation and development, by using numerical simulations based
on a mathematical model. A map of the genetic events presented in [38] is not known for
HCC but, according to [62, 30], it shall involve at least three pathways: the p53, RB and
Wnt/β -Catenin signaling transduction pathways (STPs). Mutations on β -Catenin genes
are involved in 12-26% of human HCC[16]. In [15], the authors developed a mouse model
to understand the role of the Wnt- and Ras-pathways in HCC. This model is described in
3.1.3 and constitutes the main source of biological material of the presented work. Before
a detailed description of the mouse model and its results, we summarize some general
aspects on the liver and its components.
3.1.2 The liver: function and organization
In brief:
The liver has a crucial role in the organism as it synthesizes and metabolizes mole-
cules by uptake of certain metabolites and release of metabolic products back to the
blood. Moreover it removes toxins from the blood. To succeed in this task, the liver
is endowed with a particular architecture and different specialized components. Re-
generation of liver architecture after toxic damage has been shown to result from an
interplay of physical forces and cell-kinetic interactions of liver components. Hence a
model mimicking carcinogenesis must take into account these components and forces.
We briefly describe here the elements that we included in the model.
In [46], the subject is introduced as follows:
1source Association pour la recherche contre le cancer (ARC)
2source cancer.org
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“The liver provides functions required to maintain homeostasis in the or-
ganism. To accomplish this, the liver synthesizes numerous essential molecu-
les of diverse sort; extracts and metabolizes a plethora of nutrients and xeno-
biotics brought into the body through the alimentary tract (and substances
entering by other routes), as well as worn-out molecules and cells; stores, ex-
ports and/or excretes the metabolic products; and neutralizes numerous for-
eign antigens and microbes from the gut. These varied functions take place
in a structurally complex, multicellular tissue with a unique angioarchitecture
that has slowly evolved to its present form.
Major features of liver structure are a functional tissue (parenchyma)
composed of at least seven distinct types of cell – hepatocytes, cholangio-
cytes, sinusoidal endothelial cells (SECs), macrophages, lymphocytes of sev-
eral different phenotypes, dendritic cells, and stellate cells – that conjointly
possess the capacities to synthesize, metabolize and eliminate a wide range
of complex molecules and to carry out immune functions, all arranged in a
matrix that facilitates their cooperative interaction.”
The authors emphasize the capital role of the organization and describes the blood
flow in the liver:
“The most fundamental feature of liver organization is a unique vascular
pattern in which afferent (supplying) and efferent (draining) blood vessels of
all sizes interdigitate uniformly, always maximally separated by parenchymal
tissue and connected almost exclusively by the smallest capillary-size vessels
(the sinusoids). Afferent blood vessels branch to form up to 8-10 orders of
diminishing size from their entrance at the liver hilum; terminal portal veins,
which supply blood to sinusoids, arise from the smallest two or three orders
of preterminal portal veins. Sinusoids are interposed between afferent ter-
minal portal veins and small efferent hepatic (‘central’) veins, which collect
sinusoidal blood and merge to form larger hepatic veins. This vascular pat-
tern provides a large volume of blood at a high flow rate through large vessels
with high compliance and capacity to supply the sinusoids at a low flow rate
and pressure. Total liver blood flow is large only because there are myriad
sinusoids.”
The smallest functional liver unit capable of performing the tasks described above
is called lobule (see figure 3.1). The lobule reflects the disposition of the vasculature
that yields a roughly hexagonal pattern composed about 4000 hepatocytes – the main
cell type of the liver – in mouse [42]. In this functional unit, the spatial organization is
made to maximize the contact surface among of the cells and the blood vessels. At the
same time, the hepatocytes must be connected to create the bile network. These three
components, the hepatocytes, the blood vessels and bile network are visible in figure 3.2
and 3.3. Hepatocyte is a differentiated cell with certain abilities that make this architecture
optimal.
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Figure 3.1: Organization in liver: From left to right, the scheme zooms in to illustrate
different scales in liver. Left: the whole organ scheme illustrates the main role of the
liver: filter the blood. Veins and arteries are split in myriad of capillary-size vessels and
reassembled. Middle: the second scale – the lobule – shows how the space is organized
to manage this task. Right: lobule section illustration presents the detail of the creation of
the bile duct and the detailed architecture of a lobule that makes it functional. Image from
embryology.ch
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(a) Schematic liver lobule with
columnar organization of the hepa-
tocytes
(b) Spatial arrangement of the liver components
Figure 3.2: Organization in liver: (a) Schematic illustration of liver lobule and (b) mag-
nification of internal organization of the components. (Images (a) and (b) from embryol-
ogy.ch)
“The hepatocyte, the major epithelial cell of the liver, performs many
crucial functions that stem largely from its strategic position between two
different environments, the blood plasma and the bile. The functions carried
out at the two fronts are distinct, which means that the hepatocyte surface is
asymmetric or polarized.” [46]
The hepatocyte polarity defines the lobule architecture. Hepatocytes make tight-junctions
with their hepatocyte neighbors and form the bile network (in green in figure 3.3(b)) and
the rest of their surface is in contact with the blood network. The architecture is crucial
because even hepatocytes with internal metabolic function correctly working could not
carry out their task if the tissue is disordered. For instance in some cancer, tumor cells
have genetic modifications that generally suppress cell specialization. In case of hepato-
cytes, if such a modification occurs, it can interfere on the cell capability to form bonds
(loss of polarity) or it can decrease the contact surface to sinusoids, which would destroy
the precise architecture and decreases the metabolic function of the liver. This is why,
in the experiment described below, experimentalists stain the tumor obtained to quantify
the differentiation of cells. A large part of the present work was devoted to explore this
phenomenon (see section 3.4, 3.3.2, 3.3.2, 3.5)
The blood is transported from the portal vein and artery through the sinusoids to the
central (hepatic) vein. The vessel network forms the structural support or “skeleton” of the
liver and encompasses about 22% of the liver’s mass/volume [33]. Sinusoid is a capillary
vessel made of SECs with special properties:
”[They] are penetrated by holes (fenestrae) and lack a basal membrane,
features that allow free egress of the fluid components and solutes of the per-
fusing blood[...]. [SECs] are surrounded by a complex mixture of molecules.
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(a) Liver sinusoid. Scanning electron micrograph of a
liver sinusoid with fenestrated endothelial cells. Image
created by Prof. Robin Fraser, University of Otago, New
Zealand and released into the public domain on 2006-05-
22 as quoted below.
(b) 3D reconstruction of liver from con-
focal micrographies. Blue spheres are the
hepatocyte nuclei, thin and full green lines
define the bile network, clear and thick
green lines the sinusoids. (Image from our
collaborators at Ifado 5.1).
Figure 3.3: Organization in liver: (a) electron micrograph and (b) 3D reconstruction from
confocal micrograhs.
The unique structure of liver endothelium and sinusoids enables the free es-
cape of fluid components of blood [...]”[46]”
Blood vessels play a crucial role as vasculature presents the skeleton of this complex
architecture. However, the precise arrangement of cells within this skeleton is orchestrated
by the balance of physical forces between the different constituents forming the liver.
More details and results on biomechanics of the vasculature can be found in section 3.3.
Conclusion:
Here we presented the principles underlying mammalian liver in general, and mouse
liver in particular. The spatial arrangement of liver constituents ensures that the liver
functionality is optimized. Modifications in liver architecture decrease the organ per-
formance. Liver function is guaranteed by different cell types and their complex orga-
nization. Cancer introduces perturbations leading to disorder in the tissue. To explain
this disorder a mathematical model must reflect liver architecture and should describe
the emergence of this architecture from the interplay of physical forces between the
liver constituents (polarity, tight-junctions, vessel stiffness,...)
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(a) Pig liver lobules. In pig, the connective tissue
delimits each lobules (Image from our collaborators
at Ifado)
(b) Representation of the lobules in the model for
mouse. The lobule mosaic is obtained by color-
ing each hepatocyte in function of its closest central
vein
Figure 3.4: Organization in liver: (a) in pig, the connective tissue enclosing each lobule
makes lobules them more distinguishable from each other than in human or mouse liver.
In the center of each lobule is a central vein and at the junctions between liver lobules are
the portal triads, composed of the portal arterioles, portal venules, and bile ducts. (b) the
liver model reproduction of the liver organization.
3.1.3 Mouse model and data
In brief:
Our collaborators at Institut national de la sante´ et de la recherche me´dical (INSERM)
(see 5.1) established a transgenic mouse model to study HCC. We present here a sum-
mary and a description of the biological material. In the mouse model, APC down-
regulates β -Catenin that is involved in cell proliferation, cell-cell adhesion, and more
generally in tumorigenesis [39]. Biologists are able to knock down the APC gene in
mutant mice suppressing APC protein production, and thus causing upregulation of β -
Catenin, which induces either excessive proliferation leading to the death of the mouse
in short time or to tumorigenesis after a few weeks or months, depending on the quan-
tity of a certain drug (AdCre / Tamoxifen) injected (see schematic illustration of the
experiment in figure 3.5). Readers interested in details and methods can refer directly
to [15].
In [15], biologists established a mouse strain to investigate whether (i) APC is func-
tional in the liver and (ii) activating β -Catenin signaling is an oncogenic event in the liver.
The mice have mutations on each strand of the DNA on the APC gene. The injection
of AdCre can remove totally APC genes in the cell suppressing APC protein produc-
tion. APC controls cellular levels of β -Catenin. Experimentalists look for β -Catenin
immunoreactivity to detect APC inactivated cells. In the same way, β -Catenin can be in-
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Figure 3.5: Experimental input: scheme of the pilot experiment that provided most of
the biological material used in this chapter. High dose of AdCre injection induces a high
cell proliferation that kills the mouse in a few weeks. A smaller dose is oncogenic and
will initiate tumor with different phenotypes. We aim at understanding the intracellular
mechanisms that trigger proliferation and the cause of the phenotypical difference among
the tumor.
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directly detected by immunostaining for GS, the product for one of its target genes in the
liver. In this situation, GS staining indicates either normal β -Catenin activity (in this case
a small about 2-cells-thick ring around the central vein in control mice), or overexpression
of β -Catenin due to a loss of APC function leading to massive appearance of GS-positive
hepatocytes.
High dose injection
After a single dose of 109 pfu of AdCre: the loss of APC in liver leads to a substantial
mortality of the treated transgenic mice: 50% of the mice died within 2 weeks of the injec-
tion, and 95% died within 2 months. On day 7 after administration of 109 pfu of AdCre,
mice presented a significant hepatomegaly, the livers being 60% bigger than those of the
controls with higher number of proliferative hepatocytes. The 70–95% of the hepatocytes
showed β -Catenin staining (direct and indirect, in nucleus and cytoplasm).
Diluted injection
After injection with 0.5× 109 pfu of AdCre: 15% of the mice died within 2 months,
whereas no mortality was observed with 0.25×109 pfu of AdCre. Ten Apc-/- mice were
analyzed; four did not contain any GS+ hepatocytes and developed no liver tumor. Among
the six mice that still possessed GS+ hepatocytes, four (67%) developed micro nodules for
a total of nine tumors (see 3.1). These HCCs were histologically typed as: well differen-
tiated (WD), moderately differentiated (MD) and poorly differentiated (PD). A molecular
analysis was performed on the tumors and has shown that level expression of some genes
decreased as the differentiation status of the tumor decreased. This has been confirmed
by additional staining performed at Leibniz-Institut fu¨r Arbeitsforschung an der TU Dort-
mund (IfADo) (see description in table 3.2). In the well differentiated phenotype the
tumor still shows a visible vascularization (ICAM-1 staining) and DPPIV staining indi-
cating the bile canaliculi. The poorly differentiated phenotype is characterized by the
absence of blood vessels within the tumor. Moreover, DPPIV – the marker labeling bile
canaliculi – is absent in poorly differentiated tumors indicating the absence of bile canali-
culi - and thereby the likely absence of tight junctions indicating missing adhesion among
tumor cells (see figures 3.6 and 3.7).
Conclusion:
The authors of [15] demonstrated that (i) APC is functional in the liver and (ii) aberrant
β -Catenin signalling is a genetic event able to initiate the development of HCC. In
the case of a high dose of AdCre injection, they showed a threshold effect of APC
depletion in liver (70%) to trigger hepatocyte proliferation. In the case of diluted dose
injection, they produced and analyzed different HCC phenotypes. In the next sections,
we present mathematical models that take into account this biological information and
suggest explanations to these experimental results.
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No. of GS+ cells in No. of tumors
Mouse Id nontumoral tissue WD MD PD HCC size, mm
1 6 4 – – 4.2, 2, 1.5, 2
2 3 – 3 – 20, 6, 8
3 1.8 – – 1 0.5
4 1.3 – – 1 3
5,6 0.6, 0.9 – – – –
Mouse 1 was killed 8 months after AdCre injection.
GS-expressing cells in nonperivenous areas per 1,000 hepatocytes.
Table 3.1: Hepatocarcinogenesis in Apc-/- mice (reproduction of Table 1 in [15])
Color Name of the marker What is labeled
Blue DAPI labels the cell nuclei
Green DPPIV labels the bile canaliculi (adhesion)
on hepatocyte’s membrane. Ideally,
it should only color the bile-side
of the hepatocytes (as it is a polar-
ity marker) but it additionally stains
parts of the sinusoidal cell mem-
brane.
Red ICAM-1 labels SEC
Yellow ICAM-1 and DPPIV Indicates a co-staining of ICAM
and DPPIV (both are present) and
reveals (after some image process-
ing) the location of the sinusoids.
In ICAM/DPPIV images what is in
green (but not yellow) is bile canali-
culi.
Table 3.2: Staining information (comments Stefan Ho¨hme)
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Figure 3.6: Experimental result: well differentiated tumor. The tumor shows visible vas-
cularization (ICAM-1 staining) and DPPIV staining indicating the bile canaliculi. See
table 3.2 for staining description. Experimental data from Colnot et al., INSERM, stain-
ing from IfADo. Scale bars size is 100 micrometers.
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Figure 3.7: Experimental result: poorly differentiated tumor. The absence of ICAM-1
staining suggests that there are no blood vessels within the tumor. DPPIV is not present
indicating the absence of adhesion among tumor cells. See table 3.2 for staining descrip-
tion. Experimental data from Colnot et al., INSERM, staining from IfADo. Scale bars
size is 100 micrometers.
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3.1.4 Specificities of the liver model
In brief:
Starting from the model [44] validated in in vitro cases and [43] validated on biologi-
cal in vivo data, we composed an extended model to study the liver tumorigenesis and
to reproduce experiments of the mouse model presented above (section 3.1.3) in silico.
This Section describes additional model specifications and assumptions. The full math-
ematical model and its implementation are described in Chapters 1 and 2. We used the
data extracted in [42] to build a representative sample of lobules. We describe here the
novelties introduced.
The questions raised by the experiments explained in 3.1.3 were new and have not
yet been addressed by [43] on liver regeneration or by [41] on multi-cellular spheroids.
They require a realistic model of tumorigenesis in a realistic organ environment, namely,
in a group of liver lobules. The mathematical model of section 1 has been taken as a
starting point and was iteratively extended and refined as a result of intense interactions
with biologists and experimentalists. As in our simulations uncontrolled production of
liver tumor cells led to a high accumulation of tumor cells close to the blood vessels,
the forces occurring between cells and vessels could be significantly larger than those
observed during liver regeneration. Accordingly, the time step size in the simulations
had to be significantly reduced and a large effort had to be devoted on solving numerical
implementation issues to face the challenge of a large liver section. We present here the
list of new mechanisms, rules and configurations. For several cases, we consider a number
of alternative model variants. For the equations, see section 1.1.2.
We explored the mechanisms and parameters of the model to observe the differences
in case of liver carcinogenesis. Due to a large number of possible combinations of the
mechanisms each combination determining a possible tumor cell phenotypes, many sim-
ulations had to be done. We present in the next sections of this chapter a selection of the
most interesting and realistic ones and the meaningful results.
1 – Initial State : The model simulates a liver section composed of 9 lobules. The
precise model set up was sampled from data obtained from a statistical analysis of confo-
cal laser scanning micrographs hence each individual lobule represents a “representative”
liver lobule [42]. The multi-lobule was designed with parameters extracted from the lobule
architecture and liver components: central veins, portal veins, sinusoids and hepatocytes
(see appendix 5.2). Other parameters were taken from literature. To avoid adding too
many parameters and modeling the difficult problem of the Glisson capsule (elastic tissue
that encapsulates the liver), the spatial domain is periodic at its boundary in the three di-
rections. The size of this liver section is 75×75×7 (in hepatocyte diameters i.e 23.3µm).
The schematic liver lobule is often represented hexagonal but the reality suggest a lobule
tessellation closer to a Voronoi diagram (see figure 3.4). For this reason, we distributed
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Figure 3.8: Models from experimental input: Model integration of the experimental input
(3.5): work aims and methods.
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(a) View of liver at simulation start. (b) Magnification of the left image cut at
the top.
Figure 3.9: Liver model: Initial state of the model. The simulation starts in a periodic
multi-lobule environment. (a) In brown, the hepatocytes and red the sinusoids. The central
vein is dark blue and portal triad is made of one portal vein in light purple, one hepatic
artery in red and bilary duct in green. In the magnification (b), the blue circles represent
hepatocyte nuclei. The light brown is the cell cytosol and the dark brown is the cell
membrane. The transparent green arrows on cells are the adhesive poles of hepatocytes.
(a) View of the initial states without healthy
hepatocytes. Only vasculature and the first
initial tumor cells is represented.
(b) Schematic view of the hepatocytes em-
bedded in is sinusoid environment.
Figure 3.10: Liver model: Model starts with one tumor cell in the center lobule of the
multi-lobule environment of 8 lobules enclosing the center lobule. The tumor cells may
be either polar or not (here the green arrows shows a polar tumor cell). In real and virtual
liver, hepatocytes, the main parenchyme cell type of liver are aligned in columns along
the sinusoids.
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randomly on an hexagonal tessellation the central veins and used a Voronoi-Delaunay li-
brary from Nick Jagiella (see 5.1) to determine the portal triads. Once an arrangement of 9
lobules is obtained, it is mirrored to connect the vessels at the periodic boundaries. Before
each tumor growth simulation, a relaxation simulation is performed with the configuration
in order to avoid artifacts.
2 – Proliferation : We assume that cells are able to re-enter the cell cycle only if the
local pressure does not exceed a critical value pq (we used the principle of Biomechanical
force for inhibition (BFI) explained in Section 1.1.2, the pressure is sum of the forces
divided by the contact area). This value is assumed to be larger for tumor cells than for
normal cells as tumor cells are known to be insensitive to contact-inhibition of prolifera-
tion. Above a second pressure threshold computed again with the forces and the contact
area (we refer to these forces as Biomechanical force for apoptosis (BFA)) pd > pq, cells
die. This assumption has been shown and is able to explain homeostasis inside mono-
layers [23]. Note that this assumption fits into the concept of “homeostatic pressure”,
recently suggested by Basan et. al. in [7] to explain tumor expansion. However, we as-
sume that the pressure is only sensed in G1 and G0. Once a cell has passed S-phase it is
committed to proceed until division. In the simulations of this work we have chosen the
tumor death threshold ptd high enough so that death of tumor cells did not occur. This
setting of the death threshold was motivated by the finding that neither necrosis nor apop-
tosis was observed in the experiments. We explored different parameters for the tumor’s
proliferation threshold. For normal hepatocytes pnq = 0 so that cells only proliferate if
neighbor cells die. pnd = 3 kPa (kilo Pascal) is enough to avoid any healthy cell death.
3 – Dumb-bell system : Additionally to the Monte-Carlo simulation that evaluates ori-
entation changes based of the change of the potential energy, we consider equations for
the torques. The equation for the torques of each cell can be calculated using the same
external forces as in the equations for the cell migration. This leads to a larger consistency
as in both, the equations for the torques and for the cell mass shifts, the same forces can
be used, and complex interactions be represented. During the mitosis cells may rotate
because of an asymmetric shape (a dumb-bell) and modify polar interaction with other
hepatocyte to form tight-junctions and the resulting bile canaliculi network.
4 – Division axis : In simulations that take place in a multi-lobule environment the
division axis of cells can be set randomly and uniformly distributed, in the direction of
cell polarity, or parallel to the closest sinusoid. We call the latest assumption Hepatocyte
sinusoid alignment (HSA).
5 – Micromotility : The random component in the cell motion (a) can be biased in the
direction of locally lowest pressure or (b) can be uniformly distributed.
6 – Cell type adhesion :
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1. Tumor cells do not adhere to hepatocytes or to sinusoids.
2. For hepatocytes, we tested two variants. (a) No adhesion to tumor cells and sinu-
soids, but adhesion to other hepatocytes. (b) When a tumor cell comes in contact
with a healthy cell, then the cell-cell contacts of the healthy cell with its neigh-
bor cells are destroyed. This mimics the effect of short-range proteolytic enzymes
secreted by tumors cells on cell-cell contacts.
3. Hepatocyte/SEC adhesion, Tumor/SEC adhesion.
7 – Polar adhesion : The cell-cell adhesion contacts of both, normal hepatocytes and
tumor cells can be either polar or non polar. The polar angle can be set differently for
healthy and tumor cells.
8 – Environment : Simulations take place either in a nine lobules environment or in a
full box of hepatocytes with no vessel network. Both configurations have the same size
and periodic conditions. The aim of studying tumor growth without any vasculature is to
establish a reference situation where the growth of the tumor (especially its shape) is not
driven by the vessel architecture.
9 – Pressure measurement : The pressure on a cell is the sum of all forces divided by
the contact area where the force is exerted. Hence, in absence of cell-cell adhesion, all
contributions are positive while in presence of cell-cell adhesion, the total pressure can
be negative (tension) or positive. In simulations it can make sense to study negative and
positive pressures, or to consider only the positive compressive contribution of the cell-
cell interaction even in case adhesive interactions are present. For this reason we consider
both measures in our simulations.
10 – Pressure gradient preferred move : The random component in the cell motion
can be biased in the direction of locally lowest pressure.
11 – Morphogen attraction : Sinusoids release a morphogen that attracts hepatocytes.
We model this SEC morphogen chemoattraction either on all cells or on tumor cells only.
12 – Cell/Cell adhesion desctruction : When a tumor cell comes in contact with a
healthy cell, then the cell-cell contacts of the healthy cell with its neighbor cells are de-
stroyed. This mimics the effect of short-range proteolytic enzymes secreted by tumors
cells on cell-cell contacts.
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13 – SEC proliferation and death : SECs growth may either be induced by vessel
stretch or by a signal [19]. SEC death is induced by pressure. If a SEC in contact with
tumor cells experience a pressure above a certain threshold, it dies. Technically, a SEC
divides, a node is added and connected to the local nodes of the graph. When a SEC dies,
the links with other nodes in the graph are removed.
14 – Individual parameter variations : Most of the parameters are not global but
individual for each cell. However, in most of the simulation, we distinguish 3 distinct
sets of parameters for 3 distinct populations: healthy, tumor and endothelial cells (the
endothelial cells make up the sinusoids). For each of the three sub-populations, we can
vary the parameters for mechanical softness (Young modulus, Poisson ratio), medium
friction, cell-cell friction (every combination of cell: tumor, healthy, endothelial), polar
angle, cycle-time, pressure threshold, etc.
Conclusion:
Due to the cancer nature, agent-based models might be naturally well suited to help in
the understanding of early carcinogenesis. The most general cancer definition could
be: “an abnormal cell proliferation caused by genetic mutations”, expressing the mon-
oclonal character of cancer formation. In agent-based models, where each cell is mod-
eled individually, it is practical and immediate to add or remove cell properties. The
difficulty is to identify the relevant properties, if they are changed by a certain mutation
and - in case they are changed - when they are changed. Cells are very complicated
and complex objects and it is today impossible to pretend to model them in complete
detail. The modeler must choose plausible assumptions and infer what is missing by
comparison to the biological information available. From the point of view of systems
theory, cancer causes a perturbation in the system. The impact on the system in the
individual case depends on what, where and how the perturbation takes place. We used
the biological information on liver carcinogenesis and adapted our model for liver to
answer certain questions that experiments only can hardly resolve.
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3.2 Mathematical modeling of β -catenin and Ras signal-
ing in hepatocyte and its impact on proliferation, tis-
sue organization and formation of hepatocellular car-
cinoma
In brief:
As a proof of concept we first integrated a simplified model of the Wnt and β -catenin –
signal transduction pathway into the multi-cellular model. We perform here integration
into a monolayer and choose the boundary condition in analogy to those in a liver
lobule. We have chosen this intermediate step – the test of the intracellular model in a
monolayer resembling a liver lobule cross-section – as it is much less simulation time
intense than the full multi-lobule model. Moreover, it isolates important phenomena
on intracellular pathways that could be hardly distinguished from other phenomena in
a more complex system.
In a fundamental first step we study if Wnt and Ras signaling pathways can explain the
observation of [15], that instantaneous proliferation in Apclox/lox mice can only be ob-
served if around 70% of the hepatocytes become Apc-/-. In the experimental model this
is performed by administration of 0.5× 109 pfu AdCre. For consistency we initially
used an intracellular model provided by our collaborators in the CancerSys project
at Charite´ at Humboldt university of Berlin (see 5.1). It turned out that this model
is insufficient to explain the aforementioned proliferation – threshold – like behavior
at 70%. We integrated a further function of APC-knockout, namely the assumption
that β -Catenin acts as a transcription factor of TGF-alpha, which then is secreted into
the extracellular space and able to activate the Ras pathway by binding to the EGF-
receptor. TGF-alpha is furthermore assumed to diffuse and hence can serve as a mes-
senger molecule informing other hepatocytes of the existing APC knockout cells. We
find that if both the production of TGF-alpha as well as its diffusion are fast enough,
it is possible to define a growth factor threshold concentration at which cell cycle en-
trance occur such that the experimentally observed proliferation threshold behavior in
Apclox/lox mice at about 70% knockout can be mimicked. TGF-alpha production had to
be strong enough such that the local growth factor concentration exceeded that in the
extracellular medium.
3.2.1 Introduction
In order to predict the effect of molecular manipulations on multi-cellular organization,
mathematical models of multi-cellular tissues must present the link between the molecular
alphabet and the cell phenotype [72] [71]. In the transgenic mouse stem considered in this
project, Wnt and Ras STPs are believed to play an important role in the development of
HCC [11, 79, 78]. For this reason, many investigations were done in the CancerSys project
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and Wnt and Ras STPs were included into a multi-cellular model [1, 52, 69].
As shown in [15] Tamoxifen triggers GS positive hepatocytes in Apclox/lox mice. The
fraction of GS positive hepatocytes depends on the dose of Tamoxifen administered. GS is
a target of β -catenin hence GS positive hepatocytes reflect nuclear presence of β -catenin.
If the fraction of GS positive hepatocytes exceeds about 70% then hepatomegaly linked to
hepatocyte proliferation was observed. Tumor formation was observed 8 or 9 months after
administration of 0.59 pfu of Tamoxifen in six of 10 mice. From these observations it is
clear that the individual hepatocyte must be able to detect how many other hepatocytes are
GS positive. Findings by [78] suggest that TGF-alpha expression is triggered by β -catenin
as the TGF-alpha gene is also a target of β -catenin. TGF-alpha is then secreted outside
the cell, and binds to the EGF receptor activating the Ras pathway. As it can diffuse,
it can bind to the EGF-receptor of the same cell that secreted TGF-alpha as well as to
the EGF-receptor of neighbor cells. As the model simulations in liver are very complex
and time-consuming – already without including the intracellular model, we consider as
a very simplified multi-cellular arrangement a monolayer representing a liver slice as we
did previously in [42] to study liver regeneration after CCl4-induced damage. So far,
the intracellular model considered a generic growth factor (named ”GF”) as well as Wnt.
The findings described above propose that TGF-alpha has to be considered in addition.
Accordingly, we first explain the intracellular model, extended by the production of TGF-
alpha. In a second step we will explain how the growth factor and Wnt diffuse in our
model. Then we will show simulations in the monolayer situation where the number of
cells has been calibrated to those in a liver slice. The transition from liver slice to the full
multi-lobule model is straightforward as the same software tool is used for both.
3.2.2 Normal hepatocytes: the intracellular model
We extend the intracellular model finally set up in the EU - project CancerSys for normal
hepatocytes by our collaborating group lead by Nils Blu¨thgen (with no mutations or APC
depletion). For reasons of consistency we use the same parameter values for those model
parts taken from our collaborators work. The simulations in the full liver multi-lobule
model are currently on the way.
Schematic model representation
Here we describe the scheme shown in figure 3.11. “Step n” denotes the considered
process, denoted by the rate constant kn.
1. Transformation of the free destruction complex DCF into the receptor destruction
complex DCR through Wnt stimulation. In fact, Wnt signaling requires the inhi-
bition of Glycogen Synthase Kinase 3 (GSK3) activity through the recruitment of
the free destruction complex DCF to the plasma membrane which then binds to a
receptor complex.
2. Degradation of DCR through endosomes, multivesicular bodies, and possibly exo-
somal secretion.
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Figure 3.11: Scheme of Wnt and Ras pathway signaling used in our model. Ras is not ex-
plicitly shown here. GF (represented here exemplarily by HGF) and TGF-alpha activates
Ras, leading to downstream activation of Erk. The different reactions are explained in the
text in 3.2.2. For a better readability of the scheme we place β -catenin production in the
nucleus. Actually, β -catenin is formed in the cytosol but triggered by expression of genes
in the nucleus. It can then enter in the nucleus and binds to transcription factor.
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3. Degradation of the unbound form of the destruction complex (DCF).
4. Natural production of DCF.
5. Inhibition of β -Catenin by DCF by phosphorylating β -Catenin thus marking it for
protosomal degradation.
6. Another form of β -Catenin synthesis.
7. Another form of β -Catenin degradation.
8. Transformation of Erk into phosphorylated Erk, pErk, through HGF stimulation.
9. Degradation of pErk.
10. DCF production activation (more precisely of the APC complex component) by
pErk.
11. Inhibition of pErK by β -Catenin.
12. Production of GS if β -Catenin concentration in a hepatocyte exceeds a certain β -
Catenin threshold in the cytosol.
13. Production of Dkk if β -Catenin concentration in a hepatocyte exceeds a certain
β -Catenin threshold.
14. Negative feedback produced by Dkk into this network. Dkk inhibits Wnt signaling
through competing for the same receptors as Wnt.
15. Degradation of GS by the proteasome.
16. ε describes the production of TGF-α which is secreted in the medium once β -
Catenin accumulates and translocates in the nucleus through APC knock-out (when
β -catenin translocates into the nucleus then it binds to Tcf/Lef transcription factor
leading to expression of the Tcf-related target genes such as TGF-α [78]). TGF-
α is secreted into the extracellular space where it binds to the EGF receptor. As
TGF-α can diffuse, it can bind to the EGF receptor of the secreting and of adjacent
cells.
Dkk (steps 13 and 14) is believed to play an important role in zonation but is not
considered below. The reader can report to [55] for more details.
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Mathematical model representation
d[DCR]
dt
= k1+ [Wnt][DCF ]− k1− [DCR]− k2[DCR] (3.1)
The term −k1− [DCR] represents the dissociation of DCR from the membrane.
d[DCF ]
dt
=−k1+ [Wnt][DCF ]+ k1− [DCR]− k3[DCF ]+ k4(1+(k10[pErk])n) (3.2)
d[pErk]
dt
= k8[HGF ][Erk]− k9[pErk]− k11[pErk][βcat] (3.3)
d[βcat]
dt
=−k5[DCF ][βcat]+ k6− k7[βcat] (3.4)
d[Wnt]
dt
= DWnt∆[Wnt]−µWnt [Wnt] (3.5)
where DWnt is the Wnt Diffusion constant and µWnt is the Wnt degradation constant
and n a natural number ¿ 1. We furthermore assume that Wnt adopts a maximum value at
the central vein which, we here identify with the center of the (mono-)layer.
d[Dkk]
dt
= DDkk∆[Dkk]+ρDkkF([Dkk])−µDkk[Dkk] (3.6)
where DDkk is the Dkk Diffusion constant, ρDkk is the Dkk production constant and
µDkk is the Dkk degradation constant. F is mimics Dkk production. In the current model,
we do not consider Dkk.
if β -Catenin exceeds a certain threshold of β -cat (β -cat > β -cat threshold)
d[GS]
dt
= k12[βcat]− k15[GS] (3.7)
If β -cat does not exceed the threshold:
[GS] = 0 (3.8)
We further make a number of assumptions:
The total destruction complex is given by the mass conservation:
[DC] = [DCF ]+ [DCR] (3.9)
We assume that the degradation of the two forms of the destruction complex DCF and
DCR occur at the same rates:
k2 = k3 = kDC (3.10)
Receptor internalization normally happens within 15min, see [37]. And since there’s
evidence that the destruction complex needs to be bound to the receptor complex before it
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can be internalized [37], receptor complex binding needs to be faster than internalization
(<15min). For this reason, we assume that the variation of the DCR in time is very small
and consider the steady state for DCR:
d[DCR]
dt
= 0 (3.11)
It is assumed that the dissociation of the receptor complex from the receptor is much
faster than the degradation of the receptor bound destruction complex. In fact, the degra-
dation of the receptor bound destruction complex happens mainly via internalization and
exosomal degradation. We suppose: k1− >> k2
The total amount of Erk (denoted by superscript ”T”) is conserved and the sum of
activated (phosphorylated) and non-phosphorylated Erk is constant:
[ErkT ] = [Erk]+ [pErk] (3.12)
We also set the derivative of pErk with respect to time to zero as pErk reaches the
steady state instantaneously because of the rapid phosphorylation of Erk [54].
d[pErk]
dt
= 0 (3.13)
and for simplicty we set [ErkT ] = 1
Because of the slow diffusion ofWnt molecule caused by palmitoylation, Dkk diffu-
sion is much faster thanWnt diffusion [81]: DDkk >> DWnt
With these assumptions we find:
d[DC]
dt
=−kDC[DC]+ k4(1+(k10[pErk])n) (3.14)
[DCF ] =
[DC]
1+ k16[Wnt]
(3.15)
k16 =
k1+
k1−
(3.16)
[pErk] =
[HGF ][ErkT ]
[HGF ]+ k17+ k18[βcat]
=
[HGF ]
[HGF ]+ k17+ k18[βcat]
(3.17)
k17 =
k9
k8
(3.18)
k18 =
k11
k8
(3.19)
The equation for the free destruction complex becomes:
d[DC]
dt
=−kDC[DC]+ k4+
(
k10[HGF ]
[HGF ]+ k17+ k18[βcat]
)n
(3.20)
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(a) (b)
(c)
Figure 3.12: Steady state in normal (healthy) hepatocytes. (a) β -Catenin, (b) free de-
struction complex [DCF ] and (c) [pErk] as a function of the Wnt and GF concentration
in the range [0 : 1] following the normalization of our collaborators on the EU-project
CancerSys.
Hence, if HGF (representing growth factors) is zero, then [DC] = k4
kDC
d[βcat]
dt
=−k8 [DC]
1+ k16[Wnt]
[βcat]+ k6− k7[βcat] (3.21)
We further assume the following initial conditions: [DC](0) = 0 and [βcat](0) = 0
Figure 3.12 shows the concentrations of β -Catenin, free destruction complex, and
pErk as a function of the Wnt and GF concentration for healthy hepatocytes. In the steady
state, β -Catenin and pErk both become a function of the GF and Wnt concentration. For
normal cells, k4 6= 0 . Hence free destruction complex is always produced.
In case of a Apc Knock-out, [DC] = 0 leading to [βcat] = k6
k7
. On the other hand,
zero Wnt-concentration increases the decay of [βcat] but due to the constant production
rate k6, [βcat] > 0. Moreover, for Apc
-/- cells, k4 = 0. Hence, free destruction complex
is not produced and consequently β -Catenin not degraded. The resulting functions for
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(a) (b)
(c)
Figure 3.13: Steady state in Apc-/- hepatocytes. (a) β -catenin, (b) destruction complex and
(c) pErk as a function of theWnt and GF concentration in the range [0 : 1] following the
normalization of our collaborators on the EU-project CancerSys. Note that the β -catenin
concentration is a constant.
β -Catenin, destruction complex and pErk are shown in figure 3.13.
3.2.3 Simple models of coupling of proliferation and apoptosis to β -
catenin and pErk
Different possible hypotheses may be supported by references and the findings in our
consortium of how β -catenin and pErk concentration on one hand as well as proliferation
and apoptosis on the other hand may be coupled.
Probability – triggered cell entrance or apoptosis
1. In a first approach we assumed that pErk and β -catenin determine the probability of
proliferation and survival by a Hill function. This corresponds to assuming a threshold-
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behavior. We assume that at a certain point in time a cell either enters the cell cycle,
becomes apoptotic or stays quiescent depending on its concentration of β -catenin and
pErk. One way of defining the probability to enter the cell cycle is:
p=
1
C
([βcat][pErk])n
θ np +([βcat][pErk])
n
(3.22)
n is the Hill exponent, θp > 0 denotes the value where the 2
nd derivative of p with
respect to [βcat][pErk] is zero. C > 0 is a normalization parameter. 0 ≤ p ≤ 1
C
. The
apoptosis probability can be defined as:
a=
1
C
[
1− [pErk]
n
θ na +[pErk]
n
]
=
1
C
θ na
θ na +[pErk]
n
(3.23)
Where θ na > 0 and 0≤ a≤ 1C . One can show that for any n> 0 and θp = θa = θ > 0,
we have 0≤ p+a≤ 2
C
. As the sum of the probabilities must be 1,C ≥ 2.
The probability of a cell to stay quiescent is then:
q= 1− p−a (3.24)
Figure 3.14 shows p, q and a for C=3 for healthy and APC-ko cells for the values of
figures 3.12 and 3.13. Note that if [GF]=0, then Erk is not activated and proliferation does
not occur while apoptosis is maximal.
2. A second model would be that only activation of Erk alone controls proliferation
and apoptosis. The effect of β -catenin on proliferation in this model is indirect: β -catenin
enters the nucleus and triggers expression of TGF-alpha, which is secreted into the extra-
cellular space. Here, it binds to the EGF-receptor and activates the Ras pathway activating
Erk and triggering proliferation. For the cell cycle entrance probability one can assume:
p=
1
C
[pErk]n
θ np +[pErk]
n
(3.25)
For the apoptosis probability:
a=
1
C
[
1− [pErk]
n
θ na +[pErk]
n
]
=
1
C
θ na
θ na +[pErk]
n
(3.26)
For the quiescence probability:
q= 1− p−a (3.27)
Figure 3.15 shows p and a for C = 2
State transition rates
One might expect that cells regularly sense the signals from their environment and re-
adapt their state and activity to the incoming signals. In such a case one would have to
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(a) (b)
(c) (d)
(e) (f)
Figure 3.14: Probability model assumption 1 for equations (3.22) and (3.23): (a) Prolif-
eration, (b) quiescence, (c) apoptosis probability for healthy cells, and (d) proliferation,
(e) quiescence and (f) apoptosis probability for APC-knockout cells for the values used in
figures 3.12 and 3.13.
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(a) (b)
(c) (d)
Figure 3.15: Probability model assumption 2 for equations (3.25) and (3.26): (a) Prolifer-
ation and (b) apoptosis probability for healthy cells, and (c) proliferation and (d) apoptosis
probability for APC-knockout cells. In both cases, the quiescent probability is q = 0.5.
The parameter values are those used in figures 3.12 and 3.13.
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replace the probabilities by rates, one for certain rate of cell cycle entrance, another rate
for cell death, and a third rate for quiescence (neither cell cycle entrance nor cell death).
Cell death could only act on non-proliferating cells.
In order to mimic the experimentally observed bell-shaped curve of a cell cycle dura-
tion (see [23] and refs. therein) the cell cycle is divided into m sub-phases and Poisson
processes are assumed to mimic the transition from one intermediate state to the next one.
The cell cycle progression rate from one state i > i+1 can be defined by λ/m where re-
lates λ = 1/τ to the cell cycle duration τ of an isolated cell. A cell at state m divides into
two quiescent cells. A quiescent cell does not enter the cell cycle with rate α . Be further
the death rate for a quiescent cell γ assuming that a proliferating cell does not die i.e., a
cell, once it entered the cell cycle, finishes the cell cycle. In most cases and in absence of
anti-mitotic drugs this gives a suitable description.
In the computer simulation the dependency of the rates on the local concentrations of
Wnt and GF (including TGF-alpha) favors algorithms with fixed time step ∆t. At time
t, one would firstly test if the cell is proliferating or quiescent. ∆t it has to be chosen
small enough such that within the time interval only a single event is likely to occur in
the whole population. Alternatively, one could chose cells in random order and make sure
that each individual cell i(i = 1, . . . ,N) can change its state only withWi∆t << 1 where
Wi denotes the total rate with which the state of the respective cell i can be left. However,
this has the risk that one cell state change affects another one in the same time interval so
usually it is favorable to choose ∆t so small that Wtotal∆t << 1 where Wtotal is the total
rate at which a given global state can be left. If for a random number η uniformly chosen
in [0,1), η <Wtotal∆t , then the configuration changes its state, otherwise no change of
the global change is performed. To choose a state change, all states accessible from the
current configuration are calculated together with its weight. Then one of them is chosen
at random taking the weight into account. As the time interval has to be chosen very
small, ∆t << 1/Wmaxtotal . Typically, ∆t << η/W
max
total with η = 0.001 – 0.01. Accordingly,
the simulations can take very long.
For the simulations in this thesis we use the first approach (approach 1.) to show proof
of concept as the last algorithm has very long simulation times.
3.2.4 Normal hepatocytes
For the simulations in this and the following sections the intracellular Wnt- and Ras-
pathways were integrated into each individual cell. Wnt and GF are assumed to be trans-
ported outside the cell. The transport considered here is by diffusion from cell-to-cell.
However, as long as no significant apoptosis occurs leading to large necrotic lesions no
significant difference of cell-to-cell diffusion from inter-cellular diffusion in the ECM is
expected. In order to be consistent with the normalization of our collaborators on the
EU-project CancerSys, the GF-concentration is set to 1 in the outer field of the monolayer
mimicking the peri-portal field, and Wnt is set to 1 at the center of the monolayer, reflect-
ing the central vein. Advection is not considered. In this way the monolayer simulation
represents a potential experimental setting. However, we also do not expect largely dif-
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(a) (b)
Figure 3.16: (a) GF concentration profiles for 2 different diffusion constants as a function
of the distance between the monolayer center (0) and the monolayer border (at 20 cell
diameters). The noisy points emerge from the random position of cells as diffusion in the
simulations was assumed to occur from cell-to-cell. (b) the GF profile in the monolayer in
2D for the smallest diffusion constant D0. The value 1 represents the source at the border.
ferent results with or without advection as the size of the diffusion constant can largely
account for the effect of advection.
Numerical solution of partial differential equations
We assumed that diffusion of Wnt and GF occurs from cell to cell. The numerical solution
of the reaction diffusion equations for Wnt and GF for a given cell i during the time step
∆t having a concentration equal to Cx with x ∈ (GF,Wnt) follows the numerical scheme
presented in 1.1.2.
Results
Figure 3.16 shows simulations results for the spatial steady state profile of GF in healthy
cells for two different GF-diffusion constants. The noise reflects neighbor irregularities,
as diffusion is from cell-to-cell. Intercellular diffusion in the ECM would damp noise
effects if the local concentrations of GF are sufficiently large.
As expected, a smaller diffusion constant results in a steeper concentration profile.
Figure 3.17 and 3.18 shows the corresponding spatial profiles of β -catenin, pErk, the
product [βcat][pErk] as well as the Hill function determining the proliferation probability.
Note that due to the product of β -catenin and pErk concentration, the slope for a small
diffusion constant has another sign as that for a large diffusion constant. Hence, the spatial
coupling by diffusion has a significant impact on the proliferation.
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(a) (b)
(c) (d)
Figure 3.17: (a) β -Catenin concentration (in log-plot) vs. distance between monolayer
border and monolayer center for two different diffusion constants. (b) corresponding plot
for pERK concentration. (c) product of β -Catenin and pERK concentration, (d) Hill-
function. Note that the gradient of the Hill-function changes sign in going from small to
large diffusion constants.
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Figure 3.18: For small diffusion constant the Hill function has its smallest value in the
center (lower), for large diffusion constant at the border (compare curves in middle line).
Note that the local value of the Hill-function evaluated at the position of a cell determines
the probability of cell cycle entrance of that cell.
3.2.5 APC depleted hepatocytes
We assumed that the depletion of APC does not modify the diffusion constant of GF or
Wnt. For example, a high β -catenin concentration emerging from APC knockout could
modify adhesion among cells and thus create disruption in the normal diffusion process.
We assume that the diffusion of growth factors necessities to be faster enough to avoid this
situation (order of few seconds which is much faster than cell properties modifications).
If β -catenin exceeds certain threshold of β -catenin (βcat > βcatthreshold) then k4 = 0
and we find for the GF:
d[GS]
dt
=−k12[βcat]− k15[GS] (3.28)
If β -catenin does not exceed the threshold, then:
[GS] = 0 (3.29)
TGF-α
Once β -catenin is over expressed and translocated into the nucleus it activates it serves
as a transcription factor for genes of several factors, for example, GS, TGF-α and Dkk.
TGF-α is secreted into the extracellular space where it can diffuse and bind to the EGF –
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(a) (b)
Figure 3.19: (a) GF profile for 4 cases: no APC ko cells, 60% APC ko cells, 70% APC
ko cells and 100%. (b) Corresponding Hill-function. For 0% APC-ko cells no TGF-α
is produced (red curve) while for 100% APC-ko cells, each cell produces growth factor
(magenta curve). For 60% and 70%, 2 different curves emerge, one that corresponds to
APC ko cells, the other one for those cells where APC is not knocked out. (0.5p is the
production term of TGF from APC ko cells, p= 106 in (seconds × cell volume)-1 )
receptor of the secreting cell and of neighboring cells and activate the Ras – pathway. For
the secretion we assume: TGFα = ε[βcat] with ε being a certain fraction in steady state.
If the cell is APC-KO, then k4 = 0. The steady states for the destruction complex and
β -catenin in case of APC-KO are respectively:
[DC] = 0 (3.30)
[βcat] =
k6
k7
(3.31)
In our simulations, we subsume TGFα into the total GF-concentration by the replace-
ment [GF ]→ [GF ] + [TGFα ]. Hence, we assume that TGF-α has the same diffusion
constant and decay rate at other GFs.
Results
The corresponding profiles found in the monolayer for Apc Knock-out are shown in figure
3.19. For 0% as well as for 100% knockout-cells the Hill-function generates a unique
curve. For 60% and 70% APC-knock-out the cells with APC-knockout produce TGF-
α and locally trigger β -catenin increase and, after secretion into extracellular space, an
increase of GF in extracellular space, and by binding to EGF-receptor, an activation of
RAS. For APC-knockout cells the Hill-function is larger than for those without APC-
knockout for the parameters considered. In this case it is impossible to find a threshold
such that proliferation occurs if 70% of the cells are APC knocked out but no or almost no
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(a) (b)
Figure 3.20: Same simulation as for figure 3.19 but with 100 times larger diffusion con-
stant. (a) GF concentration and (b) Hill-function for Apc Knock-out cells have approxi-
mately the same value of β -catenin and pErk. To distinguish them we had to increase the
production of TGF (see figure 3.21).
proliferation occurs in case 60% of the cells are APC knocked out. Moreover the diffusion
of GF is slow such that cells in APC-knockout – rich cell patches accumulate GF so the
60% and 70% APC-ko - curves show a large overlap.
Only increasing the diffusion constant of the growth factor did not help (figure 3.20).
Still 60% and 70% could not be distinguished.
Only after in addition to the increase of the GF-diffusion constant also the produc-
tion rate of growth factor was increased it was possible to define a threshold capable of
distinguishing between 60% and 70% APC-knockout cells.
Figure 3.23 shows simulations where in the monolayer the cell cycle entrance after
administration of tamoxifen is mimicked for a cell layer without Apc Knock-out , Figure
3.24 the corresponding pictures with Apc Knock-out . The parameters are the same as for
figure 3.21.
Coupling to cellular phenotype
In figure 3.25, we investigate which cells enter the cell cycle at 50% and 70% APC-
knockout hepatocytes, respectively. At 50% almost no cell cycle entrance is observed in
the model. The remaining very small number of cell cycle entrance may disappear once
we also include free diffusion in intercellular space while so far we have only considered
cell-to-cell diffusion. For 70% APC-knock out a significant fraction of cells enters the
cell cycle.
It turned out that the dynamics is very important. We first calculated the proliferation
profile starting from the steady state of the β -catenin concentration which led to results
incompatible with the experimental findings. In this case, all cells entered the cell cy-
cle. Moreover, if the GF were not removed fast enough from the environment it may
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(c)
Figure 3.21: (a) Growth factor and (b) Hill-function if in addition to the increase of the dif-
fusion constant (see figure 3.20) also the production rate of TGF-alpha was increased. (c)
Magnification of the upper right picture. Due to the fast diffusion, GF is homogeneously
distributed and due to the large production rate of TGF-alpha, a distinction between 60%
case and 70% case by a threshold becomes feasible.
Figure 3.22: Legend color for probabilities: from 0 (black) to 1 (white).
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(a) (b)
(c) (d)
Figure 3.23: Simulations: for cells without APC knockout. Computation of concentra-
tions and pathways for normal cells in a monolayer with a ring of sources of GF at the
border and Wnt in the center. (a) GF diffusion is fast enough to generate a moderately in-
creasing gradient of GF concentration from the border. (b) Wnt sources trigger β -catenin
only for the cells close to the center. (c) The probability of apoptosis is higher in the center
while (b) the probability of proliferation is very homogeneous.
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(c)
Figure 3.24: Same simulations as for cells without APC knockout (see figure 3.23) here
for APC knockout cells. (a) GF diffusion is fast and the high number of sources fills the
domain. (b) Wnt sources provide only the cells close to the center with Wnt. (c) The
probability of proliferation is 1 in the tumor center (light blue are cell sources not taken
into account for the computation of the pathways). APC ko cells do not show dependence
on the Wnt concentration. Every APC-knockout cell has a high probability to enter the
cell cycle as the GF concentration is high enough.
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(a) (b)
Figure 3.25: Simulation of cell cycle entrance with (a) 50% APC ko cells and (b) 70%
APC ko cells. Brown cells are without APC-knockout, gray cells are quiescent APC ko
cells, white cells are proliferating APC ko cells. The threshold is reached for almost all
APC ko cells in the 70% case in only 16 hours.
accumulate and induce proliferation.
In figure 3.25, we mimicked the full dynamics from the moment on the cells became
Apc-/-.
3.2.6 Outlook
The procedure outlined above opens the option to study molecular effects in multi-cellular
organ environments. We have demonstrated this here for monolayers choosing the bound-
ary conditions such that they reflect a liver lobule. However, as we used the same software
as for tumor genesis in multi-lobules, we are currently running the simulation in full organ
environment.
The results show that considering the spatial arrangement of cells instead of only
individual cells can make a big difference. Moreover, information from higher scales can
help to identify missing control units or links on the intracellular molecular scale.
Both steps studying the impact of cell-level parameters on the tumor phenotype and in-
tegrating the intracellular molecular model into each individual cell need to be performed
separately. The reason is that not all influences of the intracellular activation patterns
on the cell-level parameters are known, so an integrated multi-scale model representing
the Wnt/Ras-modules within each cell and coupling them to the known cell parameters
proliferation and apoptosis may be insufficient to explain the experimentally observed
growth pattern. Indeed, proliferation and apoptosis alone seem insufficient to explain the
occurrence and the pattern of the well differentiated and poorly differentiated tumor phe-
notypes. As suggested in later section, interactions between sinusoidal endothelial cells
and tumor cells are likely to be crucial to understand emergence of well-and poorly differ-
entiated tumor phenotypes. This could only be found from studying the effect of cell-level
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parameters on the tumor phenotype independently of the intracellular molecular alphabet.
On the other hand knowing the possible cell level parameters capable to explain the ex-
perimentally observed phenotypes gives valuable hints to additional functions of Wnt- or
Ras- pathway activation effects, or to alternative pathways that may be activated during
carcinogenesis.
3.3 Model prediction on vasculature in case of disordered
division
In brief:
The liver functions are dependent on the liver tissue organization. In this tissue, the
vasculature plays a crucial role. In this section, we show a sensitivity analysis of the
model on the vessel stiffness and relate it to the well-differentiated phenotype.
3.3.1 Introduction
As emphasized in section 3.1.2, the liver functionality is totally dependent on its archi-
tecture. It has been observed in section 3.1.3 that poorly and well-differentiated tumors
create disorder in the tissue organization. For poorly differentiated tumors, the sinusoids
are simply removed from the tumor center (see explanation in section 3.4) whereas in
well-differentiated tumor, vasculature remains in the tumor but is slightly disordered. In
figure 3.26, we can see a magnification of a well-differentiated tumor. The co-staining of
sinusoid in red and the hepatocyte membrane in green produces a yellow-like color in the
healthy tissue whereas they are clearly separated in the tumor nodule.
In case of rapid cell proliferation, additionally to the force already present (cell/cell
adhesion, cell/cell repulsion, cell/SEC adhesion, cell/SEC repulsion), the cell growth ex-
erts a force that distorts the surrounding vasculature. The response of the vasculature is
proportional to the Young modulus of the endothelial cells it is composed of. This feed-
back effect determines the pattern of the vasculature. We make a sensitivity analysis of
this parameter and demonstrate its importance in resulting tumor phenotype. We compare
different scenarios using a value found in the literature for in vivo liver sinusoids [9].
3.3.2 Vessel stiffness
In tumor, mechanical properties changes could be either the result of cell phenotype mod-
ification or, inversely, a factor that induces cancer [51]. In both cases, a better under-
standing of the interplay between the tumor phenotype and the biomechanical properties
of the tissue constituents cells and vessels may on the long run permit a better diagno-
sis. Hepatocytes are differentiated cells. Their main function is linked to blood exchange
(metabolic functions, detoxification, etc.) and their spatial arrangement. Within the model
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(a) Magnification of figure 3.6 (b) Magnification of figure 3.6
Figure 3.26: Well-differentiated tumor magnifications of figure 3.6. Magnification of a
well-differentiated tumor at the tumor border. All markers appear in healthy and tumor
tissue but the tumor tissue is clearly disordered.
we represented hepatocyte properties that we believe influence the spatial arrangement of
hepatocytes and tumor cells in the lobule and consequently their contact with the blood.
Cells (hepatocyte or tumor cell) have mechanical capabilities in relation with blood cells
that we consider: polarity (an asymmetric shape that is orientated for communication and
exchange), morphogen attraction by SEC, HSA, cell/SEC adhesion as properties which
inherently require a sinusoid in the spatial neighborhood of a cell; without the presence
of the sinusoid, such cell properties cannot persist. We study the case of vasculature de-
struction in section 3.4 that provides a possible explanation for the emergence of a poorly
differentiated tumor. For well-differentiated tumors, the vasculature remains in the tumors
but is disordered (see figure 3.26). To better understand this phenomenon, we tested the
influence of the vessel stiffness on the tumor phenotype.
We considered a wide range vessel stiffness: Young moduli of 20 Pa, 1000 Pa, and
infinitely stiff vessels (see formula that relates the Young modulus and stiffness in section
1.1.2). At Young moduli above 100 Pa, the forces between blood vessels and cells can
become very large so that the time step in the simulation has to be chosen extremely small
to avoid numerical artifacts. It leads to very long simulation time longing (up to a month in
certain cases). We find, that the growth velocity of the tumor does not change significantly
with the vessel stiffness (data not shown), while the phenotype shows significant changes.
With increasing vessel stiffness more vessels remain within the tumor as this is observed in
the well-differentiated tumor phenotype. On the other hand if the vessel stiffness is small,
the expanding tumor is able to push the vessels aside so that inside the tumor almost no
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vessel is found (see figure 3.27).
Tumor cells may secrete proteolytic enzymes that could weaken the vessels, which
within the mathematical model corresponds to the case of soft vessels. In case of too
soft vessels, the model predicts a vessel depletion within the tumor and high vessel den-
sity at the tumor border which is not observed (see schematic representation in figure
3.29). With very high stiffness (for numerical reason we approximated it as infinite and
in these simulations vessels cannot move), the vasculature remains inside the tumor like
in well-differentiated tumors. On the other hand, vessels seem not that stiff if we refer to
experiments conducted on liver sinusoids in [9] that estimates the stiffness at 1000 Pascal.
Moreover, if healthy hepatocytes would offer no resistance to tumor cells and die easily
upon compression by tumor cells, then tumor cells would replace one by one the healthy
hepatocytes. Like in case of liver regeneration, the order would be maintain at least as it
is shown in [43], the surface contact fraction between cells and endothelial cells would
recover a normal value and the total number of cells in the liver would approximately
remain unchanged.
3.3.3 Results:
Soft vessels are pushed aside by tumor cells (figure 3.27(a)). For infinitely stiff vessels,
the proliferation is not stopped by the rigidity of the vasculature. The compression of the
tumor cells does not prevent proliferation (figure 3.27(b)). With 1000 Pa stiffness for the
vessel, the result is an intermediate case which shows the continuity between very soft
and very hard vasculature (figure 3.27(c)).
3.3.4 Discussion
Simulations demonstrate that the order in well-differentiated tumor is mainly controlled
by the vasculature organization. Indeed, major hepatocyte mechanisms that organize the
tissue like HSA, morphogen attraction, cell/SEC adhesion are dependent on the local ves-
sel density. Thus, a large distortion of the vasculature that induces a vessel depleted tumor
core would lead to a tumor phenotype very similar to poorly differentiated ones (except
that the staining would be different and a high vessel density would remain at the border).
With the value of 1000 Pa, we found in literature for sinusoids Young moduli, the vascu-
lature is soft enough to be disorganized but depletion of tumor vessels does not occur. We
could exclude that a slower tumor growth and/or a lower BFI threshold would produce
well-differentiated tumor phenotype (results in Sections 3.6.2 and 3.6.8). With the bio-
logical information available – parameter values from literature, staining that suggests the
presence of specific hepatocyte mechanisms – the model reproduces qualitatively well-
differentiated tumor phenotypes. A quantification of the proliferation rates and the local
vessel density would be sufficient to calibrate the model parameters to permit fitting of
experimental data for well-differentiated tumors.
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(a) Soft vessels (b) Stiff vessels
(c) Moderately stiff vessels
Figure 3.27: Vessel distortion: Results from tumor growth simulations: (a) the tumor
weakens blood vessels which permits the tumor to push them aside. On the contrary, (b)
the vessels are fixed and cannot be pushed by the tumor. (c) is an intermediate case (1000
Pascal).
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Figure 3.28: The disorder in the tumor can be seen from the contact-area fraction (see
section 1.1.3 ). In simulation with infinitely stiff vessels, the tumor replaces the healthy
hepatocyte without disturbing the vasculature. After passing an initial transient phase
the contact area fractions Healthy/SEC and Tumor/SEC are in agreement. In the 1000
Pascal simulation, a significant fraction of vessels are pushed towards the border and the
Tumor/SEC contact area fraction remains below the Healthy/SEC curve.
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(a) Not observed experimentally (b) Observed experimentally
Figure 3.29: Schematic representation of the vessel density in simulations. The left
scheme shows the simulated phenotype obtained with very soft vessels. On the other
hand, the right scheme represents a well-differentiated tumor. Because the vasculature
depends on the vessel stiffness, if the vessels are very stiff, the tumor remains vascular-
ized but contrary to liver regeneration: the tissue is disordered.
Conclusion:
The homogeneity of the vessel network depends on the ratio among the vessel stiff-
ness and the velocity and strength of the growth. With the experimental value of 1000
Pascal for the vessel stiffness, a totally uncontrolled proliferation creates vessel deple-
tion within the tumor. To calibrate the model, one needs quantitative data on vessel
architecture in well-differentiated tumors and data on the tumor development. The next
section shows another sensitivity analysis that also emphasizes the determinant role of
the vasculature.
3.4 Poorly differentiated tumor: a sufficient condition on
cell phenotype
In brief:
In the mouse model, biologists observed poorly differentiated tumor after APC cell
depletion. This tumor phenotype is characterized by the absence of blood vessels. We
integrated this information by including destruction of vasculature by tumor cells and
performed a sensitivity analysis.
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(a) Magnification of figure 3.7 (b) Magnification of figure 3.7
Figure 3.30: Poorly differentiated tumor: this tumor phenotype lost specific hepatocyte
functions like tight junction formation. It results in a disordered tissue that clearly iden-
tifies the tumor. At the tumor border, the red staining shows traces of SEC that gradually
disappear in the tumor center.
3.4.1 Introduction
In section 3.2, we explain the plausible mechanisms that could trigger proliferation in Apc
Knock-out cells. However, these mechanisms do not explain the cause of the different
phenotypes. As outlined in previous section, Wnt and HGF (or other GF) stimulated
activation of the down-stream pathways affect proliferation and apoptosis. Indeed, as
explained in section 3.1.3, in the first experiments, once the proliferation is triggered, the
mouse has very low chances to survive its hepatomegaly, which prevents observation of
tumor formation. One way to investigate if activating β -Catenin signaling is an oncogenic
event in the liver is to injecte lower dose of AdCre. Surprisingly the results show two
distinct tumor phenotypes with the same experimental protocol. The poorly differentiated
phenotype presents a major distinction: the absence of vascularization in the tumor (see
figures 3.30(a) and 3.30(b)).
3.4.2 Vasculature destruction
As described in the section 3.1.3, experimentalists found two significantly different tumor
phenotypes. The poorly differentiated phenotype (less frequent) is characterized by 2
aspects: there is almost no vascularization inside the tumor and tumor cell/normal cell
adhesion is absent. The latter can is suggested by the lack of DPPIV staining: DPPIV
stains bile canaliculi that are enclosed by tight junctions. Hence the absence of DPPIV
directly demonstrates the lack of bile canaliculi. Thus, DPPIV is a signature of adhesion
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(a) Not observed experimentally (b) Observed experimentally
Figure 3.31: Vessel density in simulations. The left scheme illustrates the phenotype
obtained when the vessels are very soft (compare also 3.3.2). The scheme on the right
side can exclusively be obtained only if vessel destruction occurs.
among hepatocytes. For that reason, missing DPPIV in a tumor can be interpreted as a
missing cohesion between tumor cells. However, a separate study on the effect of cohesion
between tumor cells led us to the conclusion that the lack of adhesion between tumor cells
alone is insufficient to explain the occurrence of a poorly differentiated tumor phenotype
(section 3.6.3).
Our next hypothesis was induced by results in section 3.3.2: a softening of the vessels
explain their depletion in the center of the tumor. Moreover, the tumor cell mass exerts a
physical stress on the vessels and stretches them. This leads at least transiently to a signif-
icant increase of vessels at the tumor margin (scheme 3.31(a)). However, this hypothesis
could not be confirmed by observations. In a next step we studied the case tumor cells
could destroy blood vessels. Such destruction may result from the secretion of proteolytic
enzymes or by compression of sinusoids such that blood cannot pass through anymore in
which case the vessels eventually dissolve [31]. In this case we find the situation repre-
sented by the scheme Figure 3.32(b).
As an alternative mechanism to destruction by a short-range proteolytic enzyme, we
considered the mechanism of blood vessel destruction by a mechanical pressure. This
mechanism was able to qualitatively reproduce the observed experiments where the tu-
mor is not vascularized and the vessel density at the border is normal. If the destruction
mechanism is efficient enough – in figure 3.32, upper right image we assumed a pressure
of 100 Pa to be sufficient for vessel destruction – then a poorly differentiated phenotype
occurs. If it is not efficient enough – in the 2nd line of Figure 3.32 we assumed the pres-
sure necessary to destruct a vessel is 500 Pa – then some vessels still remain within the
tumor and higher vessel density is observed at the border of the tumor. Thus, additional
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information and tumor growth speed (permitting to infer the pressure exerted by the tu-
mor), vessel destruction rate and vessel density (giving information on the death pressure
threshold) would permit to calibrate the model to fit the biological data.
We added the possibility of the vasculature destruction for different tumor cell phe-
notype: TC/TC adhesion, HSA division, Cell/TC adhesion, etc. (results not shown). The
results do not show significant differences and suggest that any aggressive tumor pheno-
type that could destroy its surrounding vasculature would produce the same outcome.
3.4.3 Discussion
The results of the simulation suggest that SEC death induced by pressure exerted from
tumor cells on the blood vessels or a short range proteolytic enzyme secreted by tumor
cells and acting on the blood vessels is a sufficient condition to explain the emergence of a
poorly differentiated tumor phenotype. However, the molecular origin of such vasculature
destruction is not known and may be diverse. The experimental data suggest that the
vessel removal is necessary and the results of the simulation show that the vessel removal
is a sufficient condition.
Conclusion:
APC depletion in cell has a strong oncogenic effect that affects many aspect of the
cells. In particular APC depletion could be a possible cause for the emergence of
aggressive tumors able to destroy the lobular vasculature. In this case, SEC death is
sufficient to reproduce poorly differentiated tumor phenotypes, whatever are the other
mechanisms and parameters of tumor phenotype as well as the molecular origin of the
SEC death. In order to find the proper parameters tumor growth rate and destruction
pressure threshold calibration of the model parameters with biological data that are not
yet present would be necessary.
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Figure 3.32: Snapshots from simulation where SEC are destructed and dissolved if pro-
liferating tumor cells exert a pressure on them that exerts a certain threshold. For the
simulations in this figure, the vessel stiffness is 3000 Pa. First line, on the left side, a
simulation that reproduces the poorly differentiated phenotype. First line, right hand side:
a magnification of the simulation image on the left hand side (the pressure threshold is
100 Pa). Second line: a simulation where the threshold for SEC removal is 500 Pa. The
destruction is not fast enough compared to the tumor’s growth so some vessels remain
inside the tumor.
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3.5 How symmetry reflects the tumor cell phenotype in
early carcinogenesis
In brief:
In sections 3.4 and 3.3, we studied the emergence of different tumor phenotypes. We
did not, however, study any mechanism affecting tumor symmetry, and how the tumor
phenotype is expected to vary with tumor size beyond a nodule size. In the rat exper-
imental model where tumors can be initiated in a controlled way, small tumors can be
observed while in human patients at the time point of clinical manifestation, tumors are
usually of centimeter size. The tumor shape at tumor initiation may reflect important
information on the underlying mechanism. Hence it is important to know if effects that
are detectible for small tumor nodules and reflect properties of the tumor cells, may
still be reflected in the tumor shape or phenotype at tumor sizes exceeding the distance
between the central and periportal vein.
3.5.1 Introduction
In the sections 3.4 and 3.3, all described tumors had a largely spherical symmetry that is
in agreement with experimental data from 3.1.3. The mice were killed after 8 or 9 months
and so the tumors obtained from this HCC model are large – they cover a volume larger
than one lobule which involve at least several dozen of thousands cells. At this size, indi-
vidual cell properties may be smoothed out. For instance, the HSA mechanism described
in [43] would be negligible if the vasculature has disappeared. The same holds true for
the tumor/healthy cell adhesion. More subtle underlying mechanisms could become in-
visible in large tumors where the disorder becomes dominant. In particular, we show in
this section that it is the case for asymmetric growth in HCC. We study early patterns and
memory effects and give an example for the transition from early to later stages of tumor
growth. We qualitatively compare the results with experimental data from literature.
3.5.2 Biological data
We recall that the understanding of tumor cell properties is crucial to define good targets
for therapy as it is expressed in [35]:
“Qualitative and quantitative characterization of initiation [of tumor] would
be of great value to understand chemical carcinogenesis and to design cancer
prevention strategies.”
In this paper, the authors investigate the tumor initiation in rat. The experiments and the
HCC model are different from what is presented in Section 3.1.3 and focus on the role
of cell replication and cell death but provide interesting information on the early stages
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of tumor development. Indeed, it is difficult to follow the development of a single tumor
over time because rats have to be killed to take a liver sample and produce the images (see
figure 3.33). Moreover, in most experiments, the animals are killed after a long period of
time to increase the probability to find a tumor which skips early carcinogenesis events
observation (in Section 3.1.3 mice are killed after 8 or 9 months). The authors confirm
the problem:
“Because initiation is a rare event affecting only a few cells within a tis-
sue and because in most models no specific markers for initiated cells are
available, direct investigation is difficult.”
Brief description of the experimental protocol and results:
In this experiment, the initiation of tumor is induced by injection of the genotoxic car-
cinogen N-nitrosomorpholine (NNM) and cells are marked with placental glutathione S-
transferase (GST-P).
1. injection of NNM
2. apoptosis wave at 12h : 45% of damage at 36h
3. regeneration of liver starts at 48h
4. day 4: liver mass decreased to 48%
5. day 13: placental glutathione S-transferase-positive (G+) single cells reaching a
maximum of 150 cm2 section area.
6. day 24: absolute liver weight back to original
The authors split the results in 3 phases:
1. Phase I, from day 0 to day 14: continuous appearance of G+ single cells and their
development to multicellular foci.
2. Phase II, from day 14 to day 28: regression of G+ cell clones. Due to the increase
in liver mass after the first 2 weeks the decrease in G+ single cells and G+ lesions
per liver was less pronounced than it appeared on histological sections.
3. Phase III, from day 28 to end: the numbers of G+ single cells and of multicellular
foci appeared to stabilize and an increase in larger foci was observed.
Interesting information:
First division of initiated cells are aligned with sinusoids (see figure 3.33). The growth
is columnar like in liver regeneration experiments. According to results of [43], this
means that initiated cells may have an aligned division.
102 CHAPTER 3. APPLICATION TO LIVER CARCINOGENESIS
(a) day 23 (b) day 28
Figure 3.33: Columnar growth in rat HCC from two different rats: (a)rat killed 23 days
after injection, (b) rat killed 28 days after injection. Stained cells (darker) have a mono-
clonal origin. The division is spatially ordered in column, which reflects cell phenotype.
Images from [35] generously provided by the authors.
3.5.3 From elongated to spherical phenotype
In [43], the authors found that hepatocytes divide along their closest sinusoids during
regeneration of liver, thus maintaining liver architecture. We referred to this order mech-
anism as hepatocyte sinusoid alignment (HSA). Simulations were performed assuming
that vessels are soft and easily extendable by the expanding tumor. Here we perform
equivalent simulations with modified tumor phenotype and a vessel stiffness of 1000 Pa,
observed experimentally [9]. We observe that an aligned division (cells respect HSA)
leads immediately to a more elongated shape (see figure 3.34, 3.35 and 3.36). However,
this effect lasts until tumor population sizes of several hundreds of cells. For tumor sizes
exceeding the distance between central and periportal vein, the elongation is expected to
be lost as the sinusoids are oriented from the periportal area towards the central vein, and
thus appear disordered on spatial scales large compared to individual size of a liver lob-
ule. Hence, such an orientation effect can only be transient and our simulations suggest
that by going from small to large tumors, asymmetries decrease, and besides, tumor cores
becomes vessel depleted preventing HSA.
Results
We have performed different realizations of the tumor growth process. The different as-
sumptions in these realizations do not affect tumor proliferation speed (data not shown).
These show that despite the many random sources (growth, micro-motility) the tendency
that tumor cells aligning along the vessels during division favor the formation of elongated
tumors compared to tumor cells that divide uniformly into a random direction is observed
in each of the realizations – meaning that the tendency is not due to particular initial con-
ditions. Figure 3.36, upper line, shows that the longest axis is about 16 times longer than
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HSA TC / SEC adhesion Elongation Duration
No No – –
No Yes + –
Yes No + +
Yes Yes ++ ++
Table 3.3: Cell phenotype and result on tumor shape.
(a) Tumor cells divide preferentially along sinu-
soids as found for normal hepatocytes during liver
regeneration (HSA)
(b) tumor cells divide into uniformly distributed
into random direction.
Figure 3.34: Snapshots of a tumor in liver without tumor cell / SEC adhesion (healthy
cells not represented, simulated time 99 hours, 32 tumor cells). Simulations with division
along sinusoids (a) produce tumor with a more elongated shape than (b) without aligned
division (see quantification in figure 3.36). The observed asymmetries are reproducible
for different realizations (computer experiments) of the tumor growth process.
the axis perpendicular to the longest axis. This means that the 16 first cells are aligned
in row. Moreover, the tumor cell surface area fraction accessible for the blood is slightly
larger for tumor cells aligning during division along the vessels than for tumor cells that
divide into random direction uniformly distributed. However, for tumor cell populations
of N > 600 cells, the area slightly drops.
For 4 distinct scenarios with same parameters but different cell phenotype, the first
divisions produce different shapes. The simulations with HSA clearly produce elongated
shape for a certain time. This effect is enhanced by TC / SEC adhesion whereas this
mechanism alone is negligible. In each case, the tumor growth speed is equal.
Discussion:
The simulations show that the aligned division mechanism is not sufficient with a 1000
pa vessel stiffness to obtain long column like in rat experiment (about 11 cells, see sam-
ple figure 3.33). Adding the tumor cell adhesion to the sinusoid endothelial cells (SEC)
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(a) Tumor cells divide preferentially along sinu-
soids as found for normal hepatocytes during liver
regeneration (HSA)
(b) tumor cells divide into uniformly distributed
into random direction.
Figure 3.35: Snapshots of a tumor in liver with tumor cell / SEC adhesion (healthy cells
not represented, simulated time 99 hours, 32 tumor cells). Again, the division along
sinusoid produce tumor with a more elongated shape in (a) than in (b). This effect is more
important with tumor cell / SEC adhesion as it is shown in figure 3.36.
(a) (b)
Figure 3.36: Quantification of the elongation in different simulations.“Elongation” de-
notes the ratio of the longest axis of the tumor divided by the shortest axis perpendicular
to it. A value of “1” denotes a perfectly spherical tumor shape. The aligned division along
the sinusoid leads to more elongated tumor shapes (purple and green curve). The initial
peak reflects the initial growth where tumor grows in a columnar order.
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(a) HSA + TC/SEC adhesion. (b) Random division alignment, no TC/SEC ad-
hesion.
Figure 3.37: Density of endothelial cell in the tumor respect to the tumor cell number.
Looking at first depleted values (above 5), the random division shows small SEC density
at day 7 as for the same number of cells, the aligned division starts at day 8.
drastically increases the elongation whereas the adhesion alone produces a spherical tu-
mor growth. Thus, in the same environment and with the same parameters, elongation
tendency clearly reflects the tumor cell phenotype. The elongation vanishes as the tumor
size increases which is amplified by the vessel depletion. The ratio of pressure exerted
by tumor growth and the vessel stiffness determines the time point at which the depletion
starts. The coupling of HSA and TC/SEC adhesion induces a columnar order that respects
original lobule order and delays the vessel depletion (see figure 3.37).
Conclusion:
Tumor cell phenotypes that could be quantified may disappear at later stage of tumor-
ous development. It is important not to look only at the final stage of the tumor (as
experimentalists as well as clinicians usually do) but on the whole development phase.
The whole analysis over time of the model permits to distinguish differences in cell
phenotypes that end with the same tumor pattern. Before converging to a spherical
symmetry, the tumor asymmetry reflects the tumor cell phenotype. Our simulations
suggest that HSA is not enough to explain the pattern of initiated cells in [35]. These
cells must not be to dedifferentiated and possess at least two hepatocyte mechanisms:
HSA and SEC adhesion.
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(a) Experimental input. (b) Simulation result.
Figure 3.38: Elongated growth by coupling division alignment and tumor cell/sinusoid
adhesion: the model provides quantitative data to measure tumor elongation. Compared
to biological data, the model suggests two necessary mechanisms to explain the pattern.
3.6 Simulation results after various stimulation patterns
In brief:
The possible number of combinations of assumptions is too large to be completely
tested. However, we performed many simulations to explore the most realistic config-
urations. We presented in previous sections the most concluding ones. To obtain them,
many simulations had to be performed. The results presented in this section are a se-
lection of those, which guided the thinking and allowed us to present a straight forward
reasoning and also to justify some affirmations in the argumentation line. Despite their
modest influence on tumor growth, the stimulation patterns presented below permitted
to understand the relevant mechanisms and discard the ones with small impact. More-
over, they obliged us to find new measurements and new strategies to reach the goals
of the previous sections. We present the results here to show that our exploration was
not restrained to only few mechanisms but covered a large span of possibilities.
3.6.1 The role of proteolytic enzymes destructing hepatocyte-hepatocyte
contacts
As a reference we considered growing tumors in a hepatocyte environment without blood
vessels. In this way the effect of blood vessels can be studied. We first compared the
difference between two models of adhesion (model option 12.) in an environment of
hepatocytes with and without vessel network (model option 1.). In these simulations,
tumor cells do not adhere to other hepatocytes as established in the reference model.
There is no bias for the random movement (model option 10.) and only the repulsive
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forces are used to compute the pressure, i.e. we only use the positive contribution of the
forces (model option 9.).
In both simulations, with and without proteolytic activity of the tumor cells on the
environmental tissue, the tumor cell population sizes are almost equal over time (figure
3.39(f)). The total number of cells including normal and cancer cells is slightly larger
in absence than in presence of proteolytic activity. Tumors grow exponentially fast but
the tumor diameters differ between the two cases. Because the numbers are close, the
difference in the radii results from different densities of the tumor cells. Both, the normal
hepatocytes as the tumor cells are more compressed in absence of a proteolytic activity.
This observation is supported by the observed difference in the spatial pressure profile (see
figures 3.39(c), 3.39(d)). If tumor cells are able to destroy contacts between hepatocytes
cells (figures 3.40(a), 3.40(b)) tumors can more easily expand into the tissue. In the
following simulations we used relatively high pressure quiescence threshold to observe the
tumor penetration in the tissue (BFI tumor 15 times higher than BFA healthy hepatocytes).
The results differ for same simulations (with/without proteolytic activity) but within
a liver lobule i.e., in the presence of blood vessels. Due the pre-existent architecture,
both, the tumor growth curves and the tumor radii are equal with and without proteolytic
activity of tumor cells on neighboring normal hepatocytes. The blood vessels stabilize
the organization of cells locally and largely compensates for the proteolytic effect of the
tumor on its environment. Indeed the destructive effect of our model has a range of one
cell layer at the border of the tumor.
3.6.2 Influence of the different pressure threshold to control tumor
growth
Using the same model but different quiescent threshold for tumors, we observe that with
smaller pQt the tumors are smaller (figure 3.41). Interestingly, even if the threshold for
quiescence of tumor pQt cells is slightly below the threshold at which the normal hep-
atocytes undergo apoptosis, some normal cells die at a second pressure threshold pDn .
The reason is that the evaluation of the pressure only takes place in the G1 phase while
once tumor cells have passed S-phase they progress in cell cycle until they divide. They
would increase in size even if the local pressure in the meantime exceeds the pressure pDn
for example, because the cell volume increases. If not stated otherwise, we have chosen
pQn = 0Pa, pDn = 3kPa, and pDt = 300k Pa (the subscript ”n” denotes normal hepatocytes,
”t” tumor cells).
3.6.3 The role of tumor cell adhesion
β -catenin is known to be able to affect adhesion between tumor cells ([72] and refs.
therein). For this reason a key mechanism to be studied was the effect of adhesion be-
tween tumor cells, or between tumor cells and endothelial cells on the tumor phenotype.
We consider the following mechanisms (snapshots of the simulations in figure 3.42):
108 CHAPTER 3. APPLICATION TO LIVER CARCINOGENESIS
(a) (b)
(c) (d)
(e) (f)
Figure 3.39: (a) A simulation of a growing tumor in multi-lobule environment after 8 days
and (c) its corresponding pressure. The tumor cells do not destroy contact between nor-
mal hepatocytes. (b) The same simulation but the tumor is able to digest bonds between
surrounding hepatocytes. (d) is the corresponding pressure of the system. (e) denotes the
number of healthy cells, (f) the tumor population size (in these simulations, blood vessels
were not considered).
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(a) (b)
(c) (d)
(e) (f)
Figure 3.40: (a) a simulation of a growing tumor in multi-lobule environment after 8
days and (c) its corresponding pressure if the tumor cells do not destroy cell-cell contacts
between normal hepatocytes. The pressure in the center (in the tumor) is higher. (b) The
same simulation if the tumor cells are able to destruct the contact between neighboring
hepatocytes. (d) is the corresponding pressure profile. The pressure is higher in the tumor.
(e) denotes the total population size, (f) the tumor cell population size (in these simulations
blood vessel were present).
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Figure 3.41: Populations of tumor cells. The lower the threshold of quiescence is earlier
the growth of the tumor cell population crosses over to sub-exponential growth.
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1. No adhesion, neither between tumor cells and endothelial cells, nor between tumor
cells and either tumor cells or hepatocytes.
2. Adhesion between tumor cells and either tumor cells or hepatocytes.
3. Adhesion between tumor cells and endothelial cells as well as between tumor cells
and hepatocytes.
While visually, it is difficult to detect differences between the different situations, a
plot of the radius of gyration versus the tumor cell numbers shows that in case of no
adhesion the tumors are least compact while in case of adhesion between tumor cells and
endothelial cells as well as tumor cells and hepatocytes, the tumors are most compact
(figure 3.43).
As shown in figure 3.44, the contact area hepatocytes shared with sinusoids shows the
largest value if tumor cells and sinusoidal endothelial cells adhere (blue curve in figure
3.44(a)). Here the contact area represents the surface area of a tumor cell, which is acces-
sible to blood, i.e. the contact area with sinusoids. If there is no adhesion between tumor
cells and sinusoidal endothelial cells, then the contact area is significantly smaller if tumor
cells adhere to other tumor cells (green curve in figure 3.44(a)). This is also reflected in
the number of sinusoidal endothelial cell (SEC) elements vs. the tumor cell population
size (green curve in figure 3.44(b)). If tumor cells cohere (and adhere with hepatocytes)
then the tumor forms a compact mass as in this case tumor-tumor cell contacts are ener-
getically favored over tumor-cell-endothelial cell contacts. This explains why the contact
area as well and the SEC vs. the tumor cell number are smaller than in the other two cases.
If tumor cells do not adhere at all, neither to other tumor cells, to hepatocytes or to sinu-
soidal endothelial cells (red curve in figure 3.44(a)), then the contact area of hepatocytes
to endothelial cells is close to the that of tumor cells that adhere to SECs. The reason is
that the pressure generated by proliferating tumor cells in the region of the tumor slightly
increases the local cell density, so tumor cells are pushed against SEC. As there are not
competing effects such as cohesion between tumor cells (as for the green curve in 3.44),
the values for contact area and SEC elements is close to that for the case where tumor
cells and SEC adhere (blue curve in 3.44).
As we demonstrate for tumor cells adhering to sinusoidal endothelial cells (SECs) but
not to other tumor cells or to hepatocytes, the contact area decreases for larger tumor sizes.
For large tumor sizes, vessels are pushed and a vessel depletion zone occurs. However,
the vessels are found to still remain within the tumor. Hence the vessel density, calculated
from sufficiently large volumes, is still maintained. Only the order of the vessel network
is affected. Hence, our simulations suggest that by going from small to large tumors,
asymmetries as well as vessel order may decrease while the number of vessels remaining
inside the tumor increases as in normal liver.
3.6.4 Tumor Cell motility
Aberrant β -catenin degradation leading to β -catenin entrance into the nucleus has been
described as a mechanism promoting tumor cell invasion. For this reason we studied
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(a) (b)
(c) (d)
(e) (f)
Figure 3.42: Snapshots from simulations. On the left side, the tumor is represented in this
environment with healthy cells. On the right side, the corresponding image where only the
tumor is represented. Proliferating tumor cells are in white, quiescent tumor cells are in
gray, dividing tumor cells are in blue, healthy cells are in brown and red when apoptotic.
In (a) and (b), the tumor cells adhere to other cells (healthy or tumorous), in (c) and (d),
tumor cells adhere to other tumor cells and to endothelial cells. In (e) and (f), tumor cells
do not adhere at all.
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Figure 3.43: Radius of gyration of different tumors with respect to the tumor cell number.
The curve legend refers to the adhesion: “TC not adhesive” means no adhesion, neither
between tumor cells nor between tumor cells and endothelial cells, “Cell/TC adh” denotes
that cell/cell adhesion is present, and “Cell/TC + SEC/TC adh” the presence of adhesion
between tumor cells on one hand, and endothelial as well as tumor cells and normal hepa-
tocytes on the other hand. We observe that the compactness of the tumor is dependent on
the adhesion mechanisms.
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(a) (b)
(c) (d)
Figure 3.44: (a) Contact area hepatocyte – sinusoid vs. logarithm of tumor cell population
size. (b) Number of SEC elements as a function of the tumor cell number. (c) plot of
endothelial cell density vs. distance from tumor border (y-axis) and time in days (x-axis:
days 1-9) for the case where tumor cells adhere to SECs but not to other tumor cells or to
hepatocytes. The red line indicates the tumor border. The tumor develops a depletion zone
in the center after about 6 days. At the same time, the endothelial cell density close to the
tumor margin but still inside the tumor increases. (d) In all considered cases, the tumor
adopt finally (at about N > 100 cells) a circular shape even though for the case of only
adhesion between tumor cells and SECs a moderate tendency towards growth along the
sinusoid can be seen. This can be seen from the “elongation” vs. N plot. The elongation
is defined as the ratio of the longest axis divided by the shortest axis. For N > 100 tumor
cells it is close to 1 saying that the longest and the shortest axes are approximately equally
long.
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how tumor cell micro-motility may affect the growth speed and phenotype of a tumor.
As shown in figure 3.45(a) the speed of growth varies only slightly without any system-
atic ordering between our reference value for the tumor diffusion constant, and smaller
or larger values of the diffusion constant. The observed variability can be explained by
stochasticity of the growth and migration process. This is supported by the figure 3.45(b).
The third power of the radius of gyration as a function of the tumor cell number shows
no clear differences indicating that the relation between tumor shape and tumor cell pop-
ulation number is insensitive to the diffusion constant. Moreover, the linear relationship
indicates that tumors are compact at least up to 100 tumor cells. We expect an effect
of micro-motility only if cells detach and follow a morphogen gradient as in cancer in-
vasion. Without such a gradient the pressure by the hepatocytes surrounding the tumor
inhibit detachment of individual tumor cells from the main tumor and migration into the
tissue environment. The fraction of surface area accessible to hepatocytes grows slowly
with the tumor cell number and saturates at about 30%. For more than about 120-150
tumor cells the curves flatten. Looking at the simulation videos suggest that at this point
the periodic boundary conditions in z-direction slightly modify the curve.
3.6.5 Tumor cell mechanical softness
It is known that some tumor cells are often softer than the cells of the tissue they originate
from. For this reason we study here the effect of reduced tumor cell elastic modulus –
the Young modulus – on the tumor expansion (figure 3.46). We observed that the tumors
are more compact for softer than for stiffer tumor cells. This can be explained as the
resistance to deformation decreases with decreasing Young (elastic) modulus. The shape
of the tumor remains unaffected by the stiffness of the tumor cells (figure 3.46).
3.6.6 Endothelial cell proliferation
As shown by [19] proliferating hepatocytes during regeneration trigger proliferation of
sinusoidal endothelial cells. For this reason we tested the assumption that endothelial
cells, once under tension, trigger endothelial cell proliferation in order to relax the tension.
In particular, we assume that proliferation is triggered if locally a two-fold stretch occurs.
Despite a decreasing vessel density within the tumor resulting from vessels stretched and
pushed out of the tumor center by proliferating tumor cells (figure 3.47), proliferation
of sinusoidal endothelial cells with this mechanism could not be observed. We believe
that the vessel network distributes the constraint over the whole network so that locally
too large stretch does not occur. This has been checked with different measures: mean
distance among SEC, mean angle, and SEC number (data not shown). The stretch could
occur only if the tumor growth was too fast for the vessel network relaxation time. We
think that this mechanism does not play a role in the tumor’s growth at least on the spatial
scale of individual liver lobules neither in its vascularization as long as the local increase
of tumor mass is not too fast.
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(a) (b)
(c) (d)
Figure 3.45: (a) log of tumor cell number vs. time. (b) radius of gyration vs. tumor cell
number. (c) contact area vs. tumor cells number. (d) snapshot from simulation with micro
motility 0.5×D.
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(a) (b)
(c) (d)
(e) (f)
Figure 3.46: Snapshots from simulation of tumor growth with different Young moduli. On
the left (a) and (c), the tumor in its environment and the right (b) and (d), the corresponding
images where only tumor cells are shown. The first line (a) and (b) shows a simulation
with tumor cell Young modulus of 450 Pa, the second line (c) and (d) a simulation with
100 Pa. We observe that the shapes all converge to the sphere despite a difference in
volume for the same number of tumor cell although they did not already reach a spherical
shape at 700 cells.
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(a) (b)
(c) (d)
Figure 3.47: (a) Snapshot from simulation where at a too large stretch endothelial cells di-
vide so that the vessel stress is relaxed. (b) Corresponding vessel density within the tumor
respect to time and tumor center distance. Vessels are pushed but not stretched enough
such that for the considered tumor sizes, vessel division does not occur. (c) Logarithm of
the fraction of the contact area between tumor cells and sinusoidal cells vs. time. The cell
cell contact is about 20% below that in normal liver. (d) at about 5-6 days a reduction of
sinusoids occur in the tumor, pushing and stretching vessels in agreement with the picture
(b).
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(a) (b)
Figure 3.48: Screenshot from simulation with BFI = 100 Pa. The large number of quies-
cent tumor cells (in gray) explains the deviation of the growth from the exponential.
3.6.7 Healthy cell death
Tumor development in the mouse model studied in this consortium indicates occurs over
several months. For example, mice have been sacrificed after 9 months after APC knock-
out and tumors been found [15]. In our models we had assumed that tumor cells of
the expanding tumor exert pressure on the surrounding hepatocytes triggering hepatocyte
apoptosis above a threshold pressure. On the other hand, tumor cells do not re-enter
the cell cycle if the pressure exerted on them exceeds another threshold value that we
referred to as BFI (see 3.2). If BFI is small, tumor cells have an increasing probability
to not re-enter the cell cycle. In order to demonstrate the effect of this parameter on
the tumor growth we varied the BFI between 100Pa and 3000Pa. A large BFI facilitates
tumor cell proliferation even at large pressures. Figure 3.48(b), shows the growth of
the cell population size vs. time in a plot of log(N) vs. time. For small tumors growth is
exponential. As the tumor size increases, a deviation from exponential growth is observed
if the BFI is small (300 Pa). With increasing tumor population size, the pressure inside
the tumor increases eventually exceeding the value for BFI. The smaller the BFI, the
smaller is the tumor size at which the pressure in the tumor center exceeds the BFI value.
Accordingly, the crossover from exponential to sup-exponential growth is expected to
occur at larger tumor sizes if the BFI is large and at smaller tumor sizes if the BFI is
small. However, eventually, it must always occur. On the other hand, we did not find any
effect of the BFI on the tumor phenotype.
3.6.8 Tumor cell-cycle entrance propensity
To further explore if the relaxation matters in the appearing tumor phenotype, we sim-
ulated tumor cells with different propensity to divide (figure 3.49). At the end of the
mitosis, the two new cells decide independently to enter or not the cell-cycle (if they un-
dergo a pressure below the BFI). Once the cell made its choice it is definitive, it stays
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(a) (b)
(c) (d)
Figure 3.49: Screenshots from simulation with different probability to proliferate and
different BFI (only tumor cells represented). (a) reference simulation with probability 1.
And BFI 3000 Pa. (b) Probability to re-enter the cell-cycle is 0.8 and BFI is 1000 Pa. (c)
Probability to divide is 0.8 and BFI 200 Pa. For all simulations, the healthy cell BFA is
200 Pa. We could not observe significant differences among the simulations. We show
here only the vessel density within the tumor respect to the radius of gyration.
quiescent. We tested different probability combined with different BFI. Those simula-
tions confirmed the previous ones; the mechanical relaxation at the studied tumor sizes
is fast enough to be insensitive to the tumor growth law (which is exponential) and thus
cannot explain difference in the tumor phenotypes.
3.6.9 Beyond small tumor nodules
We studied the effect of larger tumors in figure 3.50(a) for tumors where tumor cells (TCs)
adhere to sinusoidal endothelial cells (SECs) but not to other tumor cells. This mechanism
has been found in Section 3.5 to resemble a well differentiated phenotype. The results for
TC-TC adhesion and no adhesion, neither among TCs nor between TCs and SECs have
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been discussed in Section 3.5 and are only shown for comparison. It turns out that with
increasing tumor size vessels are pushed out of the center (figure 3.50(b)). However, they
are not moved to the tumor border, but stay within the tumor. As the sinusoidal network is
modified inside the tumor, the angle distribution of the vessel elements is modified (figure
3.50(c)). However, as the SEC depletion zone in the tumor center is accompanied by a
SEC high density zone at its border but still within the tumor, the total number of SECs
inside the tumor changes with the tumor cell population size as for small tumor sizes
(figure 3.50(d)). In figure 3.51, we show a 2D projection of SEC in contact with tumor
cells and within the tumor.
3.6.10 Simulation of drug injection
The model setting
In this final section we made a first very simple step towards including cell death as it
occurs during drug therapy in a simplified caricature of a tumor. However, the model
framework permits readily an application of the framework to treated tumor nodules in
the multi-lobule model. In this section we considered tumor cells as not adhesive (Hertz
force) while (healthy) hepatocytes were assumed to be adhesive and modeled by the JKR-
model. Several other options and parameters were as in previous simulations. We here did
not model the blood vessels as there influence on cell death due to drug effects are small
as long as the tumor is sufficiently vascularized which can be assumed to be the case for
tumors not exceeding the size of a lobule. Consequently, cell division cannot be oriented
along vessels so is random and uniformly distributed, no morphogen attraction, no hepa-
tocyte - sinusoid adhesion, and no tumor cell - sinusoid adhesion is considered. The vessel
plays an important role in remodeling the tissue architecture so is interesting to consider
them in re-growth. However, in any case as the simulations considering sinusoids, central
and periportal veins are an order of magnitude slower than those without blood vessels,
one would in any case in a first step perform exploring simulations without blood vessels
before considering the whole organ model with the correct micro-architecture.
We further assume that healthy hepatocytes are quiescent and die if and only if they
have been in contact with a tumor cell and experience a pressure larger than 200 Pa. This
pressure effect might rather mimic an apoptotic signal, as usually much larger pressures
are needed to kill healthy cells. However, the consequence would be the same. Tumor
cells are proliferative unless they experience a pressure higher than 3000 Pa. We consid-
ered periodic boundary conditions, where the thickness of the box was 5 cell diameters in
z-direction, and 75 cell diameters in x-and y-direction.
Results
Typical spatial tumor profiles in a cross section are shown in figure 3.52 12 hours after
drug treatment if no cell, 10% of cells, 90% of cells, or 99% of cells are killed by the drug
and phagocytized. Interestingly, even for 90% cells, the emerging tumor depletion zone
is filled with cells despite macrophages have not been considered.
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(a) (b)
(c) (d)
Figure 3.50: (a) The contact area between tumor cells and SECs drops significantly be-
yond a tumor cell population size of several hundreds of cells. (b) SEC density vs. time
in days (x-axis) and distance from tumor center (y-axis). From day 6, a depletion zone
appears inside the tumor. However, around the depletion zone, the SEC density is higher
than in normal liver tissue. As indicated by the red line the high-density SEC-zone is
inside the tumor border (shown by a red line). (c) The depletion zone modifies the angle
distribution of the sinusoidal elements indicating that tumor cells bend the vessel network.
The oscillations below 5 days indicate transient relaxation effects. (d) The SEC number
remains unaffected by the tumor cell population size confirming that the depletion zone
is enclosed by a zone of stronger vascularization. Different from the case of soft vessels
with low stiffness (Section 3.2) the zone of stronger vascularization is inside the tumor so
the total number of SECs forming the sinusoidal network inside the tumor still increases
linearly with the tumor cell number with the same slope as for small tumors. Moreover,
the number of SECs grows with the number of TCs with the same slope as the number of
SECs with the number of hepatocytes in normal non-tumor liver (short light blue line).
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(a) (b)
Figure 3.51: 2D projection in case of SEC/TC adhesion of the SEC in contact with the
tumor (green) and within the tumor (red). The tumor is compact and it is possible to
compute its the convex hull. We then can distinguish SECs that are inside the convex hull
from them that are outside. The convex hull is computed with the tessellation library from
Nick Jagiella.
Figure 3.53 shows the corresponding regrowth curves. They are all exponential up
to several 10000 cells. The radius of gyration grows linearly for the non-sensitive tumor
(0%) killed and the one where 10% was killed. For the tumors with 90% and 99%, re-
spectively, re-growth of the radius of gyration is strongly delayed. This is because the
90% and 99% first re-grows to fill the gap at almost zero cell compression until it starts to
sense the presence of the other cells. Hence the compactness of the tumor increases when
it feels the presence of the (healthy) hepatocytes.
The different scenarios are reflected in the pattern and pressure profiles after 2 days
(figures 3.54,3.55,3.56,3.57). The larger the tumor, the larger is the compression from
the surrounding tissue. Consequently, the mechanical stress in the most drug-sensitive
tumors (90% and 99%) passes intermediately small values (figures 3.56 ,3.57) while the
insensitive tumor (figure 3.54) and the low sensitive tumor (figure 3.55 ) do not. For
the most drug sensitive tumor (99%), even after 4days the compression is still moderate.
This explains the slow convergence to compactness in figure 3.53 for the most sensitive
tumor phenotype. However, interestingly, the in all cases re-growth occurs to solid com-
pact tumor phenotypes. We conclude that without a change of the cell phenotype, the
external pressure exerted by the surrounding hepatocytes seems to be sufficient to ensure
maintenance of a solid tumor phenotype.
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(a) (b)
(c) (d)
Figure 3.52: Simulations 12hours after drug injection (death is immediate). (a) 0% killed,
(b) 10% killed, (c) 90% killed, (d) 99% killed. Brown cells: healthy cells, white cells:
proliferating tumor cells, gray cells: quiescent tumor cells (not appearing here), red cells:
apoptotic cells, blue cells: tumor cells in mitosis.
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(a) (b)
(c) (d)
Figure 3.53: Plots of the 4 different cases. Growth curves are parallel (a) and compactness
equivalent for the same number of tumor cells (b). (c) For about 4 days the radius of
gyration is very low in the 99% case because the tumor is sparse after drug injection.
Only then regrowth of the radius of gyration starts despite the number of cells is already
increasing. This is reflected also in the compactness measure (d) vs. time. With increasing
time the third power of the radius of gyration divided by the number of cells divided by
the time decreases for the almost depleted tumor until the depletion zone generated by the
drug is filled with tumor cells again (Figure 3.52).
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(a) (b)
Figure 3.54: (a) Simulation with resistant tumor after 2 days. (b) The corresponding
pressure. (same legend for all images)
(a) (b)
Figure 3.55: Simulations with 10% killed at the beginning. No detectable difference in
tumor pressure can be found after 2 days (compare right picture to figure 3.54(b)).
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(a) (b)
(c) (d)
Figure 3.56: Simulations with 90% killed (2 time points). After 2 days the pressure
is much lower than for the insensitive (0% cell kill) and low sensitive (10%) cell kill
tumor. However, after 4 days the pressure profile becomes indistinguishable from the low
sensitive tumor at day 2 (compare figure 3.55(b)).
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(a) (b)
(c) (d)
Figure 3.57: Simulations with 99% killed at the beginning (2 time points). ). After 2
days and even after 4 day the pressure is much lower than for the insensitive (0% cell kill)
and low sensitive (10%) cell kill tumor (compare figure 3.56(b)). Nevertheless the tumor
regrows to a compact solid tumor.
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Conclusion:
In the simulation results presented above, most parameters have only a modest influ-
ence on either tumor growth kinetics or phenotype. However, building on precise ex-
ploration of simulated tumor phenotypes, we could exclude some that were originally
thought as good candidates and understand better the mechanisms needed to reproduce
experimental data. We could show that the effect of proteolytic enzyme in the liver, the
cell motility, the cell mechanical softness, the endothelial cell proliferation, the healthy
cell death and the cell rates are negligible in physiological range in multi-lobule envi-
ronment. We could also show the consistency of the model for pressure threshold and
for large tumors. For this study, we introduced new measures like endothelial cell den-
sities in tumors, endothelial cells in contact with tumor cells, etc. These new measures
permitted to find quantitative differences between tumor cell phenotypes. Finally, we
performed a first step towards simulating the impact of a drug therapy and we present
the first results in an environment consisting only of hepatocytes.
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Chapter 4
Summary and other applications
4.1 Summary
The model that we developed and presented in this thesis takes place in the realm of
systems biology research, a relatively recent domain of science that works on different
scales. It approaches problems like in experimental sciences does, but in contrast to which
the experiments are conducted in computer software. In many contexts and especially in
biology, agent-based models are good candidates for this type of modeling. They pro-
vide a direct approach in which all individual information is immediately available. We
implemented and adapted an agent-based model, validated in vitro and in vitro [43, 41],
to apply it to the study of liver tumor. In this model, cells are represented as dumb-bell
and each element follows this equation of motion that takes into account the mechanical
properties of the elements:
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Model simulations are very demanding. They imply a large number of elements and ask
for numerical accuracy and rigorous conditions. A large part of the work has been nec-
essarily invested in implementation and optimization. Efficient algorithms have been cre-
ated to work with recent techniques of parallelization and provide software able to solve
rigorously the large system of equations. We managed to create the first liver model able
to analyze multiple cancer phenotypes in 3D in a multi-lobule environment. Moreover,
the implementation is generic. It makes the code easily adaptable to other applications.
Today the software is already applied to close models.
The spatial arrangement of liver constituents ensures that the liver functionality is op-
timized. Modifications in liver architecture decrease performance of the organ. Liver
function is guaranteed by different cell types and their complex organization. Cancer in-
troduces perturbations leading to disorder in the tissue. To explain this disorder the math-
ematical model was enhanced to reflect liver architecture and how architecture emerges
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from the interplay of physical forces between the liver constituents (polarity, tight-junctions,
vessel stiffness,...). We based our work on data from [15] where the authors demonstrated
that (i) APC is functional in the liver and (ii) aberrant β -Catenin signalling is a genetic
event able to initiate the development of HCC. In the case of a high dose of AdCre injec-
tion, they showed a threshold effect of APC depletion in liver (70%) to trigger hepatocyte
proliferation. In the case of diluted dose injection, they produced and analyzed different
HCC phenotypes (well and poorly differentiated). We adapted the mathematical model
to take into account this biological information and suggest explanations to these experi-
mental results. During the research process, we iterated with our partners to identify the
plausible mechanisms. We finally established step by step a reference model and tested
the different combinations.
The first results presented have been obtained in monolayer culture. The results show
that considering the spatial arrangement of cells instead of only individual cells can make
a big difference: hepatocyte proliferation could be explained only with homogeneous con-
centrations of growth factors. Moreover, information from higher scales can help to iden-
tify missing control units or links on the intracellular molecular scale. Both steps studying
the impact of cell-level parameters on the tumor phenotype and integrating the intracellu-
lar molecular model into each individual cell need to be performed separately. The reason
is that not all influences of the intracellular activation patterns on the cell-level parameters
are known, so an integrated multi-scale model representing the Wnt/Ras-modules within
each cell and coupling them to the known cell parameters proliferation and apoptosis may
be insufficient to explain the experimentally observed growth pattern. Indeed, prolifer-
ation and apoptosis alone seem insufficient to explain the occurrence and the pattern of
the well-differentiated and poorly differentiated tumor phenotypes. Interactions between
sinusoidal endothelial cells and tumor cells are likely to be crucial to understand emer-
gence of well and poorly differentiated tumor phenotypes. This could only be found from
studying the effect of cell-level parameters on the tumor phenotype independently of the
intracellular molecular alphabet. On the other hand knowing the possible cell level param-
eters capable to explain the experimentally observed phenotypes gives valuable hints to
additional functions of Wnt- or Ras- pathway activation effects, or to alternative pathways
that may be activated during carcinogenesis.
Simulations performed in liver suggest that the homogeneity of the vessel network
depends on the ratio among the vessel stiffness and the velocity and strength of the growth.
With the experimental value of 1000 Pascal for the vessel stiffness, a totally uncontrolled
proliferation creates vessel depletion within the tumor. To calibrate the model, one needs
quantitative data on vessel architecture in well-differentiated tumors and data on the tumor
development.
APC depletion in cell has a strong oncogenic effect that affects many aspect of the
cells. In particular APC depletion could be a possible cause for the emergence of aggres-
sive tumors able to destroy the lobular vasculature. In this case, SEC death is sufficient
to reproduce poorly differentiated tumor phenotypes, whatever are the other mechanisms
and parameters of tumor phenotype as well as the molecular origin of the SEC death. In
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order to find the proper parameters tumor growth rate and destruction pressure threshold
calibration of the model parameters with biological data that are not yet present would be
necessary.
Tumor cell phenotypes that could be quantified may disappear at later stage of tu-
morous development. It is important not to look only at the final stage of the tumor (as
experimentalists as well as clinicians usually do) but on the whole development phase.
The whole analysis over time of the model permits to distinguish differences in cell phe-
notypes that end with the same tumor pattern. Before converging to a spherical symmetry,
the tumor asymmetry reflects the tumor cell phenotype. Our simulations suggest that HSA
is not enough to explain the pattern of initiated cells in [35]. These cells must not be to
dedifferentiated and possess at least two hepatocyte mechanisms: HSA and SEC adhe-
sion.
Most parameters have only a modest influence on either tumor growth kinetics or
phenotype. However, building on precise exploration of simulated tumor phenotypes,
we could exclude some that were originally thought as good candidates and understand
better the mechanisms needed to reproduce experimental data. We could show that the
effect of proteolytic enzyme in the liver, the cell motility, the cell mechanical softness,
the endothelial cell proliferation, the healthy cell death and the cell rates are negligible in
physiological range in multi-lobule environment. We could also show the consistency of
the model for pressure threshold and for large tumors. For this study, we introduced new
measures like endothelial cell densities in tumors, endothelial cells in contact with tumor
cells, etc. These new measures permitted to find quantitative differences between tumor
cell phenotypes. Finally, we performed a first step towards simulating the impact of a drug
therapy and we present the first results in an environment consisting only of hepatocytes.
4.2 Other on-going applications
The model implementation has already been distributed to simulate related problems (cel-
l/tumor growing population). The necessary adaptations are currently made in a collabo-
rative work.
1. Syne2Arti: Franc¸ois Bertaux, Szymon Stoma and Gregory Batt (Inria) applied the
model in Syne2Arti (Synthetic networks to artificial tissues) ANR project, which
aims to develop methods to support the rational design of artificial tissues by com-
bining computational biology and synthetic biology approaches. Cells are engi-
neered such that the expected behavior of the tissue emerges from cell interactions.
In particular, focus is made on a tissue homeostasis system: the goal is to design in
silico and construct in vivo a tissue that autonomously maintains its cell density at a
desired level. Here, the software provides a realistic framework for cell growth, di-
vision and motion. It also permits to implement easily various intra-cellular models
inside each cell, allowing to realize in silico experiments (at the “Petri dish” scale)
for each set of intra-cellular components that could be added into cells (4.1).
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Figure 4.1: Other application of the model and code: a simulation of population evolving
in a Petri dish for the Syne2Arti ANR project.
2. Game of life project: Franc¸ois Bertaux, Szymon Stoma and Gregory Batt (Inria) in
collaboration with a synthetic biology group in MIT, the Weiss lab. Yeast cells has
been engineered to play the famous Conway’s “game of life” cellular automaton,
where cells decide to die when they have either too much or too few neighbors,
and divide in-between. Here, cells produce a diffusive molecule that is released
in the medium, permitting to create concentration gradients related to the spatial
configuration of cells. This molecule binds to receptors at each cell surface and
induces death pathways when binding is either too high or too low. The software is
used in combination with image analysis procedures to guide experiments and help
the tuning of the system. More precisely, it is first calibrated to reproduce growth
of the yeast strain constructed where “killing” and “communication” modules are
off. In a second step, experiments involving those two modules are conducted,
and obtained results allow characterizing their model parameters using in silico
computations of identical experiments (4.2).
3. Ibrahim Cheddadi is currently building a continuous model of cell aggregates that
is compared to the ABM model presented here. The comparison focuses on the
mechanical properties of both models; the purpose is to suggest hybrid model to
combine the advantages of both approaches.
4. Annabelle Ballesta and Franc¸ois Bertaux started a collaboration to produce tumor
spheroid and understand the results of [48].
5. Chadha Chettaoui used the model to model the trophoblast formation in bovine.
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Figure 4.2: in silico seeding of cells according to experimental data
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Chapter 5
Appendix
5.1 Collaborations
• System toxicology group at Ifado. Responsible: Pr. Jan Hengstler. Address:
Leibniz-Institut fu¨r Arbeitsforschung an der TU Dortmund Ardeystr. 67 D - 44139
Dortmund. email: hengstler@ifado.de, webpage: www.ifado.de
• INSERM U1016, CNRS UMR 8104, Universite´ Paris Descartes at Institut Cochin,
Department of Endocrinology, Metabolism and Cancer, Team : Oncogenesis of
digestive epithelia. Address:24, rue du fbg St Jacques 75014 PARIS. Sabine Colnot
email: sabine.colnot@inserm.fr
• Group of Systems Biology of Molecular Networks, in Laboratory of Molecular
Tumor Pathology (Charite´) and the Institute of Theoretical Biology (HU Berlin).
Address: Charite - Universita¨tsmedizin Berlin Institut fu¨r Pathologie Chariteplatz
1D 10117 Berlin. webpage: sys-bio.net. Nils Blu¨thgen. email: nils@sys-bio.net
• Izbi, Group: Multicellular systems biology. Address: Interdisciplinary Center for
Bioinformatics University of Leipzig Ha¨rtelstr. 16-18 D-04107 Leipzig Germany.
webpage: www.msysbio.com. Stefan Ho¨hme, email: hoehme@izbi.uni-leipzig.de
• INRIAAddress: Domaine de Voluceau BP 105 78153 ROCQUENCOURT FRANCE.
Team BANG. webpage: www.inria.fr. Collaborative Members: Dirk Drasdo, Nick
Jagiella, Chadha Chettaoui, Franc¸ois Bertaux, Ibrahim Cheddadi, Annabelle Ballesta.
5.2 Parameters and model options
5.3 switches
The simulator takes as an input a set of switches that defines the model assumptions. The
list below shows the possible combination of assumptions. Most of them can be selected
independently from the others.
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Name in the simulator Model assumption
__X_PERIODIC Set the domain periodic in X direc-
tion
__Y_PERIODIC Set the domain periodic in Y direc-
tion
__Z_PERIODIC Set the domain periodic in Y direc-
tion
__POLAR_ADHESION Modulate the force with the polarity
of the cells
__PRESSURE_GRADIENT Pressure gradient for the preferred
random move
__ONLY_REPULSION Take only the repulsive pressure into
account in the pressure computation
__KEEP_BONDS_FORCE Tumor cell does not destroy adhesion
among healthy hepatocytes
__DESTROY_BONDS_FORCE Tumor cell does destroy adhesion
among healthy hepatocytes when
touches one
__TUMOR_SEC_ADHESION_FORCE Model of adhesion between tumor
cells and SEC
__TUMOR_ADHESION Define if the tumor cell is adhesive or
not to other cells
__BENDING_FORCE Tissue property of the trophoblast to
make it grow as a sphere
__CONTACT_INHIBITION Define a contact inhibition rule for
cell division in Bax* model
__SEC_STRETCH_GROWTH Endothelial cells can proliferate when
they are too stretched
__SEC_LENGTH_GROWTH Endothelial links grow if they are in
contact with tumor cell and divide
when they are too stretched
__ENDOTHELIAL_DEATH Endothelial cells can die due to pres-
sure
__MORPHOGEN_ATTRACTION Add a morphogen attraction between
SEC and Cell0
__TUMOR_MORPHOGEN_ATTRACTION_ONLY Restrict morphogen attraction to tu-
mor cells only
__DIVISION_DIRECTION_RANDOM Align cells division randomly
__SINUSOID_DIVISION_DIRECTION Align cells with the closest sinusoid
at birth (else random)
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__DIVISION_DIRECTION_NEIGHBOR Align cells with the closest at birth
(else random)
__DIVISION_POLARITY_DIRECTION Divide in the mother cell polarity di-
rection (no random)
__CELL_CELL_DIFFUSION Compute diffusion of Wnt and GF
from cell to cell
__MEDIUM_DIFFUSION Add free diffusion of a messenger in
the medium
__SUB_SUB_FRICTION Compute friction between sub-
element
__EXACT_SOLUTION Define a matrix, a Cholesky factor-
ization of the matrix and a copy of the
solution.
__ITERATIVE_SOLUTION Use the speed of the last iteration and
make iterations
__MOVE_ONLY_CELLS Move only cells in liver model where
there exists other types. For some
tests: should be off always and re-
moved
__SET_ZDIRECTION_ZERO An easy way to get monolayer: put
everything in z coordinate to 0.
__SET_YDIRECTION_ZERO An easy way to get monolayer (if
combined with z = 0, 1D model for
mechanical analysis): put everything
in y coordinate to 0.
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5.4 parameters
index Name value unit
hepatocyteInitialDiameter 23.3 micrometer [42]
centralVeinInitialDiameter 42 micrometer [42]
sinusoidInitialDiameter 7.0832 micrometer [42]
medium_viscosity_bio 1000 N · s ·m−2 [24]
single_bond_energy_bio 1.10−19 Newton [8]
diffusion_constant_cells_bio 1.10−16 m2 · s−1 [23]
cell_cell_adhesion_density_bio 1e+15 m−2 [13]
cycletime_bio 57600 second –
mitosistime_bio 7200 second –
cycletime_variance_bio 7200 second –
youngModuleBioHepatocyte 450 N ·m−2 [59]
poissonRatio 0.4 no dimension [3]
hepatocyteDistanceAfterDivision 18.64 micrometer –
springConstantSinusoids 1000 Pascal [9]
cell_cell_friction_bio 3.1007 N · s ·m−3 [24]
cell_sinusoid_friction_bio 3.1007 N · s ·m−3 –
youngModuleBioSinusoid 600 N ·m−2 –
youngModuleBioVein 1000 N ·m−2 –
pressureHepatocytesToQuiescence -500 Pascal –
pressureHepatocytesToDie 200 Pascal –
pressureTumorToQuiescence 3000 Pascal –
pressureTumorToDie 300000 Pascal –
lysisBioTime 7200 second –
apoptosisBioTime 1800 second –
apoptosisVarianceBioTime 3600 second –
sphaseBioDuration 14400 second –
morphogenAttractionRange 1.5 Cell diameter –
morphogenAttractionStrength 50 Newton –
pressureEndothelialCellToDie 200 Pascal –
probaCycleEntrance 1 no dimension –
xliverSize 1.74983 millimeter –
yliverSize 1.71954 millimeter –
zliverSize 0.163333 millimeter –
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Glossary
β -Catenin β -Catenin is a protein that plays a role in various aspects. It acts on adhe-
sion : cell junction, contact inhibition; it is involved in liver biology including liver
development liver regeneration following partial hepatectomy, HGF-induced hep-
atomegaly, liver zonation, and pathogenesis of liver cancer; especially, it is involved
in the Wnt STP [76, 83]. 52, 57, 59, 69, 72, 73, 75, 76, 82, 96, 132, 141
DAPI DAPI is a fluorescent stain that binds strongly to DNA. It is used extensively in
fluorescence microscopy. Since DAPI will pass through an intact cell membrane, it
may be used to stain both live and fixed cells. For fluorescence microscopy, DAPI is
excited with ultraviolet light. When bound to double-stranded DNA its absorption
maximum is at 358 nm and its emission maximum is at 461 nm. (This emission
is fairly broad, and appears blue/cyan.) DAPI will also bind to RNA, though it
is not as strongly fluorescent. Its emission shifts to around 500 nm when bound
to RNA. DAPI’s blue emission is convenient for microscopists who wish to use
multiple fluorescent stains in a single sample. Apart from labeling cell nuclei, the
most popular application of DAPI is in detection of mycoplasma or virus DNA in
cell cultures . 60
DPPIV Dipeptidyl peptidase-4 (DPP4), also known as adenosine deaminase complexing
protein 2 (ADA) or CD26 (cluster of differentiation 26) is a protein that, in humans,
is encoded by the DPP4 gene. The protein encoded by the DPP4 gene is an anti-
genic enzyme expressed on the surface of most cell types and is associated with
immune regulation, signal transduction and apoptosis. It is an intrinsic membrane
glycoprotein and a serine exopeptidase that cleaves X-proline dipeptides from the
N-terminus of polypeptides. Furthermore, it appears to work as a suppressor in the
development of cancer and tumors. CD26/DPPIV plays an important role in tumor
biology, and is useful as a marker for various cancers, with its levels either on the
cell surface or in the serum increased in some neoplasms and decreased in others .
59, 60, 96, 97
ICAM-1 (Inter-Cellular Adhesion Molecule 1) also known as CD54 (Cluster of Differen-
tiation 54) is a human gene. The protein encoded by this gene is a type of intercellu-
lar adhesion molecule continuously present in low concentrations in the membranes
of leukocytes and endothelial cells. 59, 60
147
148 Glossary
APC Adenomatous polyposis coli(APC) is a protein that in humans is encoded by the
APC gene. APC is classified as a tumor suppressor gene. Tumor suppressor genes
prevent the uncontrolled growth of cells that may result in cancerous tumors. The
APC protein helps control how often a cell divides, how it attaches to other cells
within a tissue, or whether a cell moves within or away from a tissue. This pro-
tein also helps ensure that the chromosome number in cells produced through cell
division is correct. The APC protein accomplishes these tasks mainly through as-
sociation with other proteins, especially those that are involved in cell attachment
and signaling. The activity of one protein in particular, β -Catenin, is controlled by
the APC protein. 4, 5, 15, 16, 57, 59, 95, 98, 132
AdCre Cre Recombinase Adenovirus (AdCre) recombines a pair of short target sequences
called the Lox sequences. This system can be implemented without inserting any
extra supporting proteins or sequences. The Cre enzyme and the original Lox site
called the LoxP sequence are derived from a bacteriophage P1. It is widely used to
carry out deletions, insertions, translocations and inversions in the DNA of cells. It
allows the DNA modification to be targeted to a specific cell type or be triggered by
a specific external stimulus. 57–60, 96, 132
Apc Knock-out Cell where APC gene has been removed and cannot encode APC pro-
teins. 75, 84, 85, 96, 148
in silico is an expression used to mean ”performed on computer or via computer simu-
lation”. The phrase was coined as an analogy to the Latin phrases in vivo, in vitro,
and in situ, which are commonly used in biology. 11, 16, 51, 52, 63, 133–135
in vitro (Latin: within glass) Refers to studies in experimental biology that are conducted
using components of an organism that have been isolated from their usual biological
context in order to permit a more detailed or more convenient analysis than can be
done with whole organisms. Colloquially, these experiments are commonly referred
to as ”test tube experiments”. 63, 131
in vivo Latin for ”within the living”) is experimentation using a whole, living organism
as opposed to a partial or dead organism. Animal testing and clinical trials are two
forms of in vivo research. In vivo testing is often employed over in vitro because it
is better suited for observing the overall effects of an experiment on a living subject.
This is often described by the maxim in vivo veritas. 63
ABM Agent-Based Model. 15, 134
Apc-/- We denote by this symbol, the APC depleted cells (see Apc Knock-out. 16, 59, 69,
75, 89
Apclox/lox We denote by this symbol, the cells where APC can be potentially removed
after tamoxifen injection. 16, 69, 70
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ARC Association pour la recherche contre le cancer. 52
BFA Biomechanical force for apoptosis. 66, 107
BFI Biomechanical force for inhibition. 66, 92, 107
chemoattractant Chemical substance that induces chemoattraction. 29
chemoattraction Themovement of a cell in response to a chemical stimulant, the chemoat-
tractant. 29, 67, 149
CSC Compressed Storage Column. 43
CSR Compressed Storage Row. 43
G+ placental glutathione S-transferase-positive. 101
GF stands for growth factor. A growth factor is a naturally occurring substance capable
of stimulating cellular growth, proliferation and cellular differentiation. Usually it
is a protein or a steroid hormone. Growth factors are important for regulating a
variety of cellular processes. Growth factors typically act as signaling molecules
between cells. 29
GST-P placental glutathione S-transferase. 101
HCC Hepatocellular carcinoma. 52, 57, 59, 69, 100, 132
hepatocyte Hepatocyte is the main cell type in liver, see Section 3.1.2. 53
HSA Hepatocyte sinusoid alignment. 66, 91, 92, 98, 100, 102–105, 133
IARC international agency for research on cancer. 52
IfADo Leibniz-Institut fu¨r Arbeitsforschung an der TU Dortmund. 59, 61, 62
INSERM Institut national de la sante´ et de la recherche me´dical. 57
JKR Johnson-Kendall-Roberts. 39
morphogen A substance governing the pattern of tissue development, and the positions
of the various specialized cell types within a tissue. It spreads from a localized
source and forms a concentration gradient across a developing tissue. 29, 67
NNM N-nitrosomorpholine. 101
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Ras is the name given to a family of related proteins. All Ras protein family members
belong to a class of protein called small GTPase, and are involved in transmitting
signals within cells. Ras is the prototypical member of the Ras superfamily of
proteins, which are all related in 3D structure and regulate diverse cell behaviors.
Because these signals result in cell growth and division, overactive Ras signaling
can ultimately lead to cancer. Ras is the most common oncogene in human cancer -
mutations that permanently activate Ras are found in 20-25% of all human tumors
and up to 90% in certain types of cancer (e.g. pancreatic cancer). For this reason,
Ras inhibitors are being studied as a treatment for cancer, and other diseases with
Ras overexpression. 4, 5, 69, 70
SEC sinusoidal endothelial cell. 53, 55, 60, 67, 68, 90, 91, 98, 103, 105, 111, 133
STP signaling transduction pathway. 52, 69, 70, 147
TGF-α Transforming growth factor alpha (TGF-alpha) is upregulated in some human
cancers. It induces epithelial development. It is closely related to EGF, and can also
bind to the EGF receptor with similar effects.. 72, 83, 84
Wnt The Wnt proteins are a group of secreted lipid-modified. These proteins activate
various pathways in the cell that can be categorized into the canonical and non-
canonical Wnt pathways. Through these signaling pathways, Wnt proteins play a
variety of important roles in embryonic development, cell differentiation, and cell
polarity generation [60]. The Wnt signaling pathway is a network of proteins best
known for their roles in embryogenesis and cancer, but also involved in normal
physiological processes in adult animals. 4, 5, 29, 52, 69, 70, 147
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